Gene to GO BP test for over-representation
| GOBPID | Pvalue | OddsRatio | ExpCount | Count | Size | Term |
| GO:0048583 | 0.00000 | 3.75275 | 31 | 78 | 3883 | regulation of response to stimulus |
| GO:0048523 | 0.00000 | 3.47259 | 37 | 85 | 4687 | negative regulation of cellular process |
| GO:0009966 | 0.00000 | 3.92446 | 22 | 63 | 2780 | regulation of signal transduction |
| GO:0048522 | 0.00000 | 3.24603 | 43 | 91 | 5469 | positive regulation of cellular process |
| GO:0048519 | 0.00000 | 3.25480 | 42 | 89 | 5278 | negative regulation of biological process |
| GO:0010646 | 0.00000 | 3.57260 | 26 | 68 | 3338 | regulation of cell communication |
| GO:0023051 | 0.00000 | 3.54477 | 26 | 68 | 3360 | regulation of signaling |
| GO:0048518 | 0.00000 | 3.14807 | 49 | 97 | 6171 | positive regulation of biological process |
| GO:0042325 | 0.00000 | 4.57877 | 12 | 44 | 1533 | regulation of phosphorylation |
| GO:0060255 | 0.00000 | 3.16202 | 43 | 90 | 5486 | regulation of macromolecule metabolic process |
| GO:0001932 | 0.00000 | 4.71609 | 11 | 42 | 1410 | regulation of protein phosphorylation |
| GO:0031323 | 0.00000 | 3.15751 | 43 | 89 | 5401 | regulation of cellular metabolic process |
| GO:0051171 | 0.00000 | 3.18189 | 40 | 86 | 5104 | regulation of nitrogen compound metabolic process |
| GO:0048731 | 0.00000 | 3.19652 | 37 | 82 | 4746 | system development |
| GO:0080090 | 0.00000 | 3.13719 | 41 | 87 | 5248 | regulation of primary metabolic process |
| GO:0007275 | 0.00000 | 3.11810 | 42 | 88 | 5362 | multicellular organism development |
| GO:0009888 | 0.00000 | 4.04981 | 15 | 49 | 1956 | tissue development |
| GO:0048856 | 0.00000 | 3.01740 | 46 | 92 | 5871 | anatomical structure development |
| GO:0032502 | 0.00000 | 2.95399 | 49 | 95 | 6258 | developmental process |
| GO:0007166 | 0.00000 | 3.62208 | 20 | 55 | 2497 | cell surface receptor signaling pathway |
| GO:0019222 | 0.00000 | 2.96104 | 47 | 92 | 5953 | regulation of metabolic process |
| GO:0019220 | 0.00000 | 4.10646 | 13 | 44 | 1692 | regulation of phosphate metabolic process |
| GO:0051174 | 0.00000 | 4.10378 | 13 | 44 | 1693 | regulation of phosphorus metabolic process |
| GO:0009968 | 0.00000 | 4.70617 | 9 | 36 | 1175 | negative regulation of signal transduction |
| GO:0048513 | 0.00000 | 3.21414 | 28 | 66 | 3504 | animal organ development |
| GO:0010648 | 0.00000 | 4.49713 | 10 | 38 | 1306 | negative regulation of cell communication |
| GO:0006915 | 0.00000 | 3.91008 | 15 | 46 | 1867 | apoptotic process |
| GO:0023057 | 0.00000 | 4.48216 | 10 | 38 | 1310 | negative regulation of signaling |
| GO:0048869 | 0.00000 | 3.03500 | 35 | 76 | 4443 | cellular developmental process |
| GO:0050789 | 0.00000 | 3.04655 | 91 | 137 | 11520 | regulation of biological process |
| GO:0006468 | 0.00000 | 3.91618 | 14 | 45 | 1815 | protein phosphorylation |
| GO:0050794 | 0.00000 | 2.93133 | 85 | 131 | 10774 | regulation of cellular process |
| GO:0031399 | 0.00000 | 3.93119 | 14 | 44 | 1760 | regulation of protein modification process |
| GO:0012501 | 0.00000 | 3.81659 | 15 | 46 | 1908 | programmed cell death |
| GO:0030154 | 0.00000 | 3.02311 | 33 | 73 | 4218 | cell differentiation |
| GO:0051716 | 0.00000 | 2.80080 | 62 | 107 | 7810 | cellular response to stimulus |
| GO:0008219 | 0.00000 | 3.70363 | 16 | 48 | 2065 | cell death |
| GO:0007154 | 0.00000 | 2.77462 | 52 | 96 | 6648 | cell communication |
| GO:0044260 | 0.00000 | 2.75909 | 56 | 100 | 7099 | cellular macromolecule metabolic process |
| GO:0007165 | 0.00000 | 2.78507 | 48 | 90 | 6028 | signal transduction |
| GO:0023052 | 0.00000 | 2.75431 | 52 | 95 | 6579 | signaling |
| GO:0050793 | 0.00000 | 3.28165 | 21 | 55 | 2721 | regulation of developmental process |
| GO:0051239 | 0.00000 | 3.11265 | 26 | 61 | 3248 | regulation of multicellular organismal process |
| GO:0051240 | 0.00000 | 3.65948 | 15 | 45 | 1929 | positive regulation of multicellular organismal process |
| GO:0016310 | 0.00000 | 3.51006 | 17 | 48 | 2166 | phosphorylation |
| GO:0065007 | 0.00000 | 2.90496 | 96 | 139 | 12135 | biological regulation |
| GO:0048585 | 0.00000 | 3.91372 | 12 | 40 | 1576 | negative regulation of response to stimulus |
| GO:0010604 | 0.00000 | 3.07586 | 25 | 60 | 3212 | positive regulation of macromolecule metabolic process |
| GO:0050896 | 0.00000 | 2.68969 | 75 | 119 | 9531 | response to stimulus |
| GO:0032501 | 0.00000 | 2.64109 | 65 | 108 | 8233 | multicellular organismal process |
| GO:0008283 | 0.00000 | 3.52656 | 16 | 45 | 1994 | cell proliferation |
| GO:0032268 | 0.00000 | 3.25539 | 20 | 51 | 2494 | regulation of cellular protein metabolic process |
| GO:0051173 | 0.00000 | 3.01532 | 24 | 57 | 3061 | positive regulation of nitrogen compound metabolic process |
| GO:0031325 | 0.00000 | 2.93547 | 25 | 58 | 3201 | positive regulation of cellular metabolic process |
| GO:0009893 | 0.00000 | 2.86161 | 27 | 61 | 3486 | positive regulation of metabolic process |
| GO:0045859 | 0.00000 | 5.29698 | 5 | 24 | 662 | regulation of protein kinase activity |
| GO:0043549 | 0.00000 | 5.02458 | 6 | 25 | 728 | regulation of kinase activity |
| GO:0051094 | 0.00000 | 3.62922 | 12 | 37 | 1540 | positive regulation of developmental process |
| GO:0051246 | 0.00000 | 2.98875 | 21 | 51 | 2687 | regulation of protein metabolic process |
| GO:2000026 | 0.00000 | 3.18434 | 17 | 45 | 2184 | regulation of multicellular organismal development |
| GO:0044237 | 0.00000 | 2.45632 | 74 | 114 | 9374 | cellular metabolic process |
| GO:0042127 | 0.00000 | 3.48384 | 13 | 38 | 1649 | regulation of cell proliferation |
| GO:2001141 | 0.00000 | 2.92808 | 22 | 52 | 2801 | regulation of RNA biosynthetic process |
| GO:0051338 | 0.00000 | 4.56565 | 7 | 26 | 832 | regulation of transferase activity |
| GO:0042981 | 0.00000 | 3.56542 | 12 | 36 | 1516 | regulation of apoptotic process |
| GO:0010941 | 0.00000 | 3.40196 | 13 | 38 | 1685 | regulation of cell death |
| GO:0043067 | 0.00000 | 3.51211 | 12 | 36 | 1537 | regulation of programmed cell death |
| GO:0051252 | 0.00000 | 2.79983 | 24 | 54 | 3049 | regulation of RNA metabolic process |
| GO:0006355 | 0.00000 | 2.86896 | 22 | 51 | 2784 | regulation of transcription, DNA-templated |
| GO:1903506 | 0.00000 | 2.85946 | 22 | 51 | 2792 | regulation of nucleic acid-templated transcription |
| GO:0051254 | 0.00000 | 3.39155 | 13 | 37 | 1638 | positive regulation of RNA metabolic process |
| GO:0032774 | 0.00000 | 2.81701 | 23 | 52 | 2896 | RNA biosynthetic process |
| GO:0019219 | 0.00000 | 2.70907 | 26 | 57 | 3352 | regulation of nucleobase-containing compound metabolic process |
| GO:0043170 | 0.00000 | 2.35155 | 67 | 105 | 8488 | macromolecule metabolic process |
| GO:0045595 | 0.00000 | 3.16657 | 15 | 40 | 1909 | regulation of cell differentiation |
| GO:0045893 | 0.00000 | 3.39148 | 12 | 35 | 1536 | positive regulation of transcription, DNA-templated |
| GO:1903508 | 0.00000 | 3.38184 | 12 | 35 | 1540 | positive regulation of nucleic acid-templated transcription |
| GO:1902680 | 0.00000 | 3.37943 | 12 | 35 | 1541 | positive regulation of RNA biosynthetic process |
| GO:0035556 | 0.00000 | 2.84264 | 21 | 48 | 2608 | intracellular signal transduction |
| GO:0001568 | 0.00000 | 4.61219 | 6 | 23 | 719 | blood vessel development |
| GO:0006351 | 0.00000 | 2.76406 | 23 | 51 | 2875 | transcription, DNA-templated |
| GO:0097659 | 0.00000 | 2.75516 | 23 | 51 | 2883 | nucleic acid-templated transcription |
| GO:0044238 | 0.00000 | 2.31540 | 74 | 112 | 9443 | primary metabolic process |
| GO:0035295 | 0.00000 | 3.77898 | 9 | 29 | 1122 | tube development |
| GO:0006464 | 0.00000 | 2.61504 | 27 | 57 | 3453 | cellular protein modification process |
| GO:0036211 | 0.00000 | 2.61504 | 27 | 57 | 3453 | protein modification process |
| GO:0008152 | 0.00000 | 2.32688 | 83 | 120 | 10485 | metabolic process |
| GO:0071704 | 0.00000 | 2.29895 | 79 | 116 | 10008 | organic substance metabolic process |
| GO:0010628 | 0.00000 | 3.03873 | 16 | 40 | 1981 | positive regulation of gene expression |
| GO:0072359 | 0.00000 | 3.70420 | 9 | 29 | 1143 | circulatory system development |
| GO:0006796 | 0.00000 | 2.70066 | 23 | 51 | 2933 | phosphate-containing compound metabolic process |
| GO:0010556 | 0.00000 | 2.60914 | 26 | 55 | 3311 | regulation of macromolecule biosynthetic process |
| GO:2000112 | 0.00000 | 2.62696 | 25 | 54 | 3219 | regulation of cellular macromolecule biosynthetic process |
| GO:0006807 | 0.00000 | 2.26946 | 70 | 107 | 8923 | nitrogen compound metabolic process |
| GO:0001944 | 0.00000 | 4.39690 | 6 | 23 | 752 | vasculature development |
| GO:0006793 | 0.00000 | 2.67727 | 23 | 51 | 2955 | phosphorus metabolic process |
| GO:0072358 | 0.00000 | 4.31734 | 6 | 23 | 765 | cardiovascular system development |
| GO:1902532 | 0.00000 | 5.13565 | 4 | 19 | 527 | negative regulation of intracellular signal transduction |
| GO:0051172 | 0.00000 | 2.86726 | 18 | 43 | 2271 | negative regulation of nitrogen compound metabolic process |
| GO:0060429 | 0.00000 | 3.60544 | 9 | 29 | 1172 | epithelium development |
| GO:0031324 | 0.00000 | 2.79738 | 19 | 45 | 2449 | negative regulation of cellular metabolic process |
| GO:0042221 | 0.00000 | 2.44313 | 33 | 63 | 4136 | response to chemical |
| GO:1902531 | 0.00000 | 3.12384 | 13 | 36 | 1710 | regulation of intracellular signal transduction |
| GO:0071900 | 0.00000 | 5.64927 | 3 | 17 | 427 | regulation of protein serine/threonine kinase activity |
| GO:0042327 | 0.00000 | 3.74960 | 8 | 27 | 1043 | positive regulation of phosphorylation |
| GO:0009892 | 0.00000 | 2.64804 | 22 | 49 | 2843 | negative regulation of metabolic process |
| GO:0006357 | 0.00000 | 2.92081 | 16 | 39 | 1993 | regulation of transcription by RNA polymerase II |
| GO:0045935 | 0.00000 | 2.99580 | 14 | 37 | 1833 | positive regulation of nucleobase-containing compound metabolic process |
| GO:0043412 | 0.00000 | 2.45983 | 29 | 57 | 3634 | macromolecule modification |
| GO:0009889 | 0.00000 | 2.47175 | 28 | 56 | 3542 | regulation of biosynthetic process |
| GO:0042326 | 0.00000 | 5.31871 | 4 | 17 | 452 | negative regulation of phosphorylation |
| GO:0045786 | 0.00000 | 5.31871 | 4 | 17 | 452 | negative regulation of cell cycle |
| GO:0031326 | 0.00000 | 2.46765 | 27 | 55 | 3470 | regulation of cellular biosynthetic process |
| GO:0010468 | 0.00000 | 2.40670 | 30 | 59 | 3860 | regulation of gene expression |
| GO:0045597 | 0.00000 | 3.55164 | 9 | 27 | 1097 | positive regulation of cell differentiation |
| GO:0048584 | 0.00000 | 2.74791 | 18 | 42 | 2294 | positive regulation of response to stimulus |
| GO:0001933 | 0.00000 | 5.53220 | 3 | 16 | 408 | negative regulation of protein phosphorylation |
| GO:0065009 | 0.00000 | 2.67939 | 20 | 44 | 2477 | regulation of molecular function |
| GO:0090304 | 0.00000 | 2.34381 | 34 | 63 | 4277 | nucleic acid metabolic process |
| GO:0010557 | 0.00000 | 2.95378 | 14 | 36 | 1799 | positive regulation of macromolecule biosynthetic process |
| GO:0070887 | 0.00000 | 2.53586 | 24 | 50 | 3023 | cellular response to chemical stimulus |
| GO:0006366 | 0.00000 | 2.83189 | 16 | 39 | 2049 | transcription by RNA polymerase II |
| GO:0034654 | 0.00000 | 2.47469 | 26 | 53 | 3310 | nucleobase-containing compound biosynthetic process |
| GO:0010562 | 0.00000 | 3.50014 | 9 | 27 | 1112 | positive regulation of phosphorus metabolic process |
| GO:0045937 | 0.00000 | 3.50014 | 9 | 27 | 1112 | positive regulation of phosphate metabolic process |
| GO:0050790 | 0.00000 | 2.93933 | 14 | 36 | 1807 | regulation of catalytic activity |
| GO:0048468 | 0.00000 | 2.68591 | 19 | 43 | 2406 | cell development |
| GO:0010605 | 0.00000 | 2.63130 | 20 | 45 | 2584 | negative regulation of macromolecule metabolic process |
| GO:0009967 | 0.00000 | 3.10322 | 12 | 32 | 1504 | positive regulation of signal transduction |
| GO:0001934 | 0.00000 | 3.62135 | 8 | 25 | 989 | positive regulation of protein phosphorylation |
| GO:0031401 | 0.00000 | 3.33857 | 10 | 28 | 1210 | positive regulation of protein modification process |
| GO:0016055 | 0.00000 | 5.25900 | 3 | 16 | 428 | Wnt signaling pathway |
| GO:0198738 | 0.00000 | 5.23313 | 3 | 16 | 430 | cell-cell signaling by wnt |
| GO:0018130 | 0.00000 | 2.41915 | 27 | 53 | 3374 | heterocycle biosynthetic process |
| GO:0060070 | 0.00000 | 6.54341 | 2 | 13 | 279 | canonical Wnt signaling pathway |
| GO:0010647 | 0.00000 | 2.85701 | 15 | 36 | 1854 | positive regulation of cell communication |
| GO:0032270 | 0.00000 | 3.04134 | 12 | 32 | 1532 | positive regulation of cellular protein metabolic process |
| GO:0043408 | 0.00000 | 4.03934 | 6 | 21 | 737 | regulation of MAPK cascade |
| GO:0019438 | 0.00000 | 2.40897 | 27 | 53 | 3386 | aromatic compound biosynthetic process |
| GO:0023056 | 0.00000 | 2.84680 | 15 | 36 | 1860 | positive regulation of signaling |
| GO:1901362 | 0.00000 | 2.37052 | 28 | 54 | 3510 | organic cyclic compound biosynthetic process |
| GO:0009987 | 0.00000 | 2.50366 | 125 | 154 | 15803 | cellular process |
| GO:0007049 | 0.00000 | 2.93438 | 13 | 33 | 1639 | cell cycle |
| GO:0007167 | 0.00000 | 3.67416 | 7 | 23 | 890 | enzyme linked receptor protein signaling pathway |
| GO:0030111 | 0.00000 | 6.23496 | 2 | 13 | 292 | regulation of Wnt signaling pathway |
| GO:0009059 | 0.00000 | 2.27818 | 32 | 60 | 4121 | macromolecule biosynthetic process |
| GO:0034645 | 0.00000 | 2.28887 | 32 | 59 | 4022 | cellular macromolecule biosynthetic process |
| GO:0043588 | 0.00000 | 6.21242 | 2 | 13 | 293 | skin development |
| GO:0031328 | 0.00000 | 2.77560 | 15 | 36 | 1903 | positive regulation of cellular biosynthetic process |
| GO:0010033 | 0.00000 | 2.42159 | 24 | 49 | 3070 | response to organic substance |
| GO:0051241 | 0.00000 | 3.11173 | 11 | 29 | 1343 | negative regulation of multicellular organismal process |
| GO:0035239 | 0.00000 | 3.60923 | 7 | 23 | 905 | tube morphogenesis |
| GO:1901700 | 0.00000 | 2.92224 | 13 | 32 | 1589 | response to oxygen-containing compound |
| GO:0016070 | 0.00000 | 2.29958 | 30 | 56 | 3761 | RNA metabolic process |
| GO:0044267 | 0.00000 | 2.21119 | 36 | 64 | 4569 | cellular protein metabolic process |
| GO:0009891 | 0.00000 | 2.71224 | 15 | 36 | 1943 | positive regulation of biosynthetic process |
| GO:0009653 | 0.00000 | 2.45598 | 22 | 45 | 2744 | anatomical structure morphogenesis |
| GO:0051093 | 0.00000 | 3.32839 | 8 | 25 | 1070 | negative regulation of developmental process |
| GO:0000165 | 0.00000 | 3.73693 | 6 | 21 | 793 | MAPK cascade |
| GO:0045944 | 0.00000 | 3.15089 | 10 | 27 | 1226 | positive regulation of transcription by RNA polymerase II |
| GO:0051247 | 0.00000 | 2.82473 | 13 | 32 | 1639 | positive regulation of protein metabolic process |
| GO:0010563 | 0.00000 | 4.35541 | 4 | 17 | 546 | negative regulation of phosphorus metabolic process |
| GO:0045936 | 0.00000 | 4.35541 | 4 | 17 | 546 | negative regulation of phosphate metabolic process |
| GO:0007399 | 0.00000 | 2.52932 | 18 | 40 | 2333 | nervous system development |
| GO:0023014 | 0.00000 | 3.65362 | 6 | 21 | 810 | signal transduction by protein phosphorylation |
| GO:0065008 | 0.00000 | 2.21181 | 32 | 58 | 4051 | regulation of biological quality |
| GO:0051726 | 0.00000 | 3.40789 | 8 | 23 | 955 | regulation of cell cycle |
| GO:0071310 | 0.00000 | 2.49080 | 19 | 41 | 2433 | cellular response to organic substance |
| GO:0008285 | 0.00000 | 3.91400 | 5 | 19 | 681 | negative regulation of cell proliferation |
| GO:1901360 | 0.00000 | 2.10682 | 41 | 69 | 5208 | organic cyclic compound metabolic process |
| GO:0045860 | 0.00000 | 4.77119 | 3 | 15 | 438 | positive regulation of protein kinase activity |
| GO:0044271 | 0.00000 | 2.19421 | 31 | 57 | 3993 | cellular nitrogen compound biosynthetic process |
| GO:0010942 | 0.00000 | 3.83054 | 5 | 19 | 695 | positive regulation of cell death |
| GO:0048870 | 0.00000 | 2.79880 | 13 | 31 | 1595 | cell motility |
| GO:0051674 | 0.00000 | 2.79880 | 13 | 31 | 1595 | localization of cell |
| GO:0060548 | 0.00000 | 3.24006 | 8 | 24 | 1049 | negative regulation of cell death |
| GO:0016477 | 0.00000 | 2.86969 | 11 | 29 | 1447 | cell migration |
| GO:0043066 | 0.00000 | 3.36341 | 7 | 22 | 921 | negative regulation of apoptotic process |
| GO:0071248 | 0.00000 | 8.16243 | 1 | 9 | 154 | cellular response to metal ion |
| GO:1905114 | 0.00000 | 4.27286 | 4 | 16 | 521 | cell surface receptor signaling pathway involved in cell-cell signaling |
| GO:0048469 | 0.00000 | 7.02220 | 2 | 10 | 198 | cell maturation |
| GO:0009790 | 0.00000 | 2.99903 | 10 | 26 | 1231 | embryo development |
| GO:0006725 | 0.00000 | 2.06218 | 40 | 66 | 5012 | cellular aromatic compound metabolic process |
| GO:0043069 | 0.00001 | 3.29470 | 7 | 22 | 939 | negative regulation of programmed cell death |
| GO:0006139 | 0.00001 | 2.06995 | 38 | 64 | 4813 | nucleobase-containing compound metabolic process |
| GO:0045596 | 0.00001 | 3.50426 | 6 | 20 | 799 | negative regulation of cell differentiation |
| GO:0009719 | 0.00001 | 2.83146 | 11 | 28 | 1409 | response to endogenous stimulus |
| GO:0033674 | 0.00001 | 4.37055 | 4 | 15 | 476 | positive regulation of kinase activity |
| GO:0046483 | 0.00001 | 2.05107 | 39 | 65 | 4940 | heterocycle metabolic process |
| GO:0045892 | 0.00001 | 3.00454 | 9 | 25 | 1177 | negative regulation of transcription, DNA-templated |
| GO:1903507 | 0.00001 | 2.99360 | 9 | 25 | 1181 | negative regulation of nucleic acid-templated transcription |
| GO:0032879 | 0.00001 | 2.29511 | 22 | 44 | 2835 | regulation of localization |
| GO:1902679 | 0.00001 | 2.99088 | 9 | 25 | 1182 | negative regulation of RNA biosynthetic process |
| GO:0051253 | 0.00001 | 2.90229 | 10 | 26 | 1269 | negative regulation of RNA metabolic process |
| GO:0070848 | 0.00001 | 3.84105 | 5 | 17 | 615 | response to growth factor |
| GO:0000188 | 0.00001 | 39.55995 | 0 | 4 | 17 | inactivation of MAPK activity |
| GO:0033993 | 0.00001 | 3.40024 | 6 | 20 | 822 | response to lipid |
| GO:0006950 | 0.00001 | 2.15057 | 29 | 52 | 3640 | response to stress |
| GO:0048568 | 0.00001 | 4.21193 | 4 | 15 | 493 | embryonic organ development |
| GO:0048514 | 0.00001 | 3.79542 | 5 | 17 | 622 | blood vessel morphogenesis |
| GO:0009058 | 0.00001 | 2.00352 | 40 | 66 | 5125 | biosynthetic process |
| GO:0009725 | 0.00001 | 3.59052 | 5 | 18 | 697 | response to hormone |
| GO:0031400 | 0.00001 | 3.93007 | 4 | 16 | 564 | negative regulation of protein modification process |
| GO:0001503 | 0.00001 | 4.70855 | 3 | 13 | 381 | ossification |
| GO:2000113 | 0.00001 | 2.77474 | 11 | 27 | 1379 | negative regulation of cellular macromolecule biosynthetic process |
| GO:0043065 | 0.00001 | 3.73204 | 5 | 17 | 632 | positive regulation of apoptotic process |
| GO:1901576 | 0.00001 | 2.00339 | 40 | 65 | 5031 | organic substance biosynthetic process |
| GO:0060828 | 0.00001 | 6.16201 | 2 | 10 | 224 | regulation of canonical Wnt signaling pathway |
| GO:0008544 | 0.00001 | 5.02739 | 3 | 12 | 329 | epidermis development |
| GO:0051248 | 0.00001 | 3.01779 | 8 | 23 | 1070 | negative regulation of protein metabolic process |
| GO:0043068 | 0.00001 | 3.70112 | 5 | 17 | 637 | positive regulation of programmed cell death |
| GO:0044249 | 0.00001 | 2.00307 | 39 | 64 | 4938 | cellular biosynthetic process |
| GO:0040011 | 0.00001 | 2.52191 | 14 | 32 | 1817 | locomotion |
| GO:0045934 | 0.00001 | 2.74026 | 11 | 27 | 1395 | negative regulation of nucleobase-containing compound metabolic process |
| GO:0032269 | 0.00001 | 3.07084 | 8 | 22 | 1003 | negative regulation of cellular protein metabolic process |
| GO:0000122 | 0.00002 | 3.25293 | 7 | 20 | 857 | negative regulation of transcription by RNA polymerase II |
| GO:0044092 | 0.00002 | 3.06106 | 8 | 22 | 1006 | negative regulation of molecular function |
| GO:0009952 | 0.00002 | 5.96500 | 2 | 10 | 231 | anterior/posterior pattern specification |
| GO:0046637 | 0.00002 | 12.55604 | 1 | 6 | 68 | regulation of alpha-beta T cell differentiation |
| GO:0051128 | 0.00002 | 2.27831 | 20 | 40 | 2558 | regulation of cellular component organization |
| GO:0046635 | 0.00002 | 12.35620 | 1 | 6 | 69 | positive regulation of alpha-beta T cell activation |
| GO:0010558 | 0.00002 | 2.70035 | 11 | 27 | 1414 | negative regulation of macromolecule biosynthetic process |
| GO:0016043 | 0.00002 | 1.92270 | 48 | 74 | 6083 | cellular component organization |
| GO:1901342 | 0.00002 | 4.84147 | 3 | 12 | 341 | regulation of vasculature development |
| GO:0046634 | 0.00002 | 9.40194 | 1 | 7 | 104 | regulation of alpha-beta T cell activation |
| GO:0009890 | 0.00002 | 2.62808 | 12 | 28 | 1509 | negative regulation of biosynthetic process |
| GO:0044093 | 0.00002 | 2.66961 | 11 | 27 | 1429 | positive regulation of molecular function |
| GO:0048732 | 0.00002 | 4.12811 | 4 | 14 | 467 | gland development |
| GO:0009628 | 0.00002 | 2.98493 | 8 | 22 | 1030 | response to abiotic stimulus |
| GO:0019538 | 0.00002 | 1.94280 | 42 | 67 | 5344 | protein metabolic process |
| GO:0022402 | 0.00002 | 2.90706 | 9 | 23 | 1108 | cell cycle process |
| GO:0007389 | 0.00002 | 4.11884 | 4 | 14 | 468 | pattern specification process |
| GO:0043405 | 0.00002 | 5.12146 | 2 | 11 | 295 | regulation of MAP kinase activity |
| GO:0071363 | 0.00002 | 3.66900 | 5 | 16 | 602 | cellular response to growth factor stimulus |
| GO:0051348 | 0.00003 | 5.58220 | 2 | 10 | 246 | negative regulation of transferase activity |
| GO:0030178 | 0.00003 | 7.31556 | 1 | 8 | 151 | negative regulation of Wnt signaling pathway |
| GO:0070373 | 0.00003 | 11.27880 | 1 | 6 | 75 | negative regulation of ERK1 and ERK2 cascade |
| GO:0071901 | 0.00003 | 8.76644 | 1 | 7 | 111 | negative regulation of protein serine/threonine kinase activity |
| GO:0071276 | 0.00003 | 27.06028 | 0 | 4 | 23 | cellular response to cadmium ion |
| GO:0001649 | 0.00003 | 6.21697 | 2 | 9 | 199 | osteoblast differentiation |
| GO:0051179 | 0.00003 | 1.89243 | 47 | 72 | 5950 | localization |
| GO:0007155 | 0.00003 | 2.70392 | 10 | 25 | 1298 | cell adhesion |
| GO:0051347 | 0.00003 | 3.74650 | 4 | 15 | 551 | positive regulation of transferase activity |
| GO:0007169 | 0.00003 | 3.73224 | 4 | 15 | 553 | transmembrane receptor protein tyrosine kinase signaling pathway |
| GO:0031327 | 0.00004 | 2.58692 | 12 | 27 | 1471 | negative regulation of cellular biosynthetic process |
| GO:0022610 | 0.00004 | 2.67719 | 10 | 25 | 1310 | biological adhesion |
| GO:0046638 | 0.00004 | 14.67250 | 0 | 5 | 49 | positive regulation of alpha-beta T cell differentiation |
| GO:0048646 | 0.00004 | 2.77524 | 9 | 23 | 1157 | anatomical structure formation involved in morphogenesis |
| GO:0006928 | 0.00004 | 2.33726 | 16 | 33 | 2014 | movement of cell or subcellular component |
| GO:0021700 | 0.00005 | 4.74865 | 2 | 11 | 317 | developmental maturation |
| GO:0002521 | 0.00005 | 3.63532 | 4 | 15 | 567 | leukocyte differentiation |
| GO:0010467 | 0.00005 | 1.92236 | 38 | 61 | 4814 | gene expression |
| GO:0002062 | 0.00005 | 8.06506 | 1 | 7 | 120 | chondrocyte differentiation |
| GO:0033554 | 0.00005 | 2.40929 | 14 | 30 | 1763 | cellular response to stress |
| GO:0071840 | 0.00005 | 1.84581 | 49 | 74 | 6266 | cellular component organization or biogenesis |
| GO:0033673 | 0.00005 | 5.75828 | 2 | 9 | 214 | negative regulation of kinase activity |
| GO:0002573 | 0.00006 | 5.70215 | 2 | 9 | 216 | myeloid leukocyte differentiation |
| GO:0010038 | 0.00006 | 5.08135 | 2 | 10 | 269 | response to metal ion |
| GO:0009605 | 0.00006 | 2.17421 | 20 | 38 | 2515 | response to external stimulus |
| GO:0043409 | 0.00007 | 6.41234 | 1 | 8 | 171 | negative regulation of MAPK cascade |
| GO:0034641 | 0.00008 | 1.84944 | 44 | 67 | 5547 | cellular nitrogen compound metabolic process |
| GO:0071241 | 0.00008 | 5.46240 | 2 | 9 | 225 | cellular response to inorganic substance |
| GO:1901564 | 0.00008 | 1.81673 | 49 | 73 | 6234 | organonitrogen compound metabolic process |
| GO:0009798 | 0.00008 | 9.14935 | 1 | 6 | 91 | axis specification |
| GO:0002724 | 0.00009 | 19.76880 | 0 | 4 | 30 | regulation of T cell cytokine production |
| GO:0048534 | 0.00009 | 2.84516 | 8 | 20 | 972 | hematopoietic or lymphoid organ development |
| GO:0061448 | 0.00009 | 4.78234 | 2 | 10 | 285 | connective tissue development |
| GO:0002376 | 0.00009 | 2.10497 | 21 | 39 | 2664 | immune system process |
| GO:0043009 | 0.00010 | 3.00758 | 6 | 18 | 824 | chordate embryonic development |
| GO:0048729 | 0.00010 | 3.24183 | 5 | 16 | 677 | tissue morphogenesis |
| GO:0007423 | 0.00010 | 3.38953 | 5 | 15 | 606 | sensory organ development |
| GO:0071495 | 0.00010 | 2.61469 | 10 | 23 | 1223 | cellular response to endogenous stimulus |
| GO:0043086 | 0.00011 | 3.21677 | 5 | 16 | 682 | negative regulation of catalytic activity |
| GO:0030155 | 0.00011 | 3.19700 | 5 | 16 | 686 | regulation of cell adhesion |
| GO:0007611 | 0.00011 | 4.66220 | 2 | 10 | 292 | learning or memory |
| GO:0045444 | 0.00012 | 5.14938 | 2 | 9 | 238 | fat cell differentiation |
| GO:0030216 | 0.00012 | 6.89846 | 1 | 7 | 139 | keratinocyte differentiation |
| GO:0009792 | 0.00012 | 2.94320 | 7 | 18 | 841 | embryo development ending in birth or egg hatching |
| GO:0007267 | 0.00014 | 2.36704 | 13 | 27 | 1596 | cell-cell signaling |
| GO:0045778 | 0.00014 | 8.27010 | 1 | 6 | 100 | positive regulation of ossification |
| GO:1903429 | 0.00014 | 17.12998 | 0 | 4 | 34 | regulation of cell maturation |
| GO:0061061 | 0.00015 | 3.12489 | 6 | 16 | 701 | muscle structure development |
| GO:0022008 | 0.00015 | 2.29096 | 14 | 29 | 1778 | neurogenesis |
| GO:0060284 | 0.00015 | 2.65487 | 9 | 21 | 1093 | regulation of cell development |
| GO:0010629 | 0.00015 | 2.28390 | 14 | 29 | 1783 | negative regulation of gene expression |
| GO:0050863 | 0.00016 | 4.46955 | 2 | 10 | 304 | regulation of T cell activation |
| GO:0006469 | 0.00016 | 5.61376 | 2 | 8 | 194 | negative regulation of protein kinase activity |
| GO:0003013 | 0.00016 | 3.57682 | 4 | 13 | 495 | circulatory system process |
| GO:0046686 | 0.00016 | 16.57668 | 0 | 4 | 35 | response to cadmium ion |
| GO:0035970 | 0.00016 | 34.87273 | 0 | 3 | 14 | peptidyl-threonine dephosphorylation |
| GO:1903430 | 0.00016 | 34.87273 | 0 | 3 | 14 | negative regulation of cell maturation |
| GO:2000145 | 0.00017 | 2.78389 | 7 | 19 | 939 | regulation of cell motility |
| GO:0045765 | 0.00017 | 4.42381 | 2 | 10 | 307 | regulation of angiogenesis |
| GO:1901214 | 0.00017 | 4.06114 | 3 | 11 | 368 | regulation of neuron death |
| GO:0051270 | 0.00019 | 2.68028 | 8 | 20 | 1028 | regulation of cellular component movement |
| GO:0002520 | 0.00019 | 2.67473 | 8 | 20 | 1030 | immune system development |
| GO:0003002 | 0.00019 | 4.00416 | 3 | 11 | 373 | regionalization |
| GO:0000278 | 0.00021 | 2.91317 | 6 | 17 | 799 | mitotic cell cycle |
| GO:0003018 | 0.00022 | 5.35256 | 2 | 8 | 203 | vascular process in circulatory system |
| GO:1901701 | 0.00022 | 2.52091 | 10 | 22 | 1206 | cellular response to oxygen-containing compound |
| GO:0071560 | 0.00022 | 5.32501 | 2 | 8 | 204 | cellular response to transforming growth factor beta stimulus |
| GO:1904018 | 0.00022 | 5.32501 | 2 | 8 | 204 | positive regulation of vasculature development |
| GO:0001525 | 0.00023 | 3.44531 | 4 | 13 | 513 | angiogenesis |
| GO:0014070 | 0.00024 | 2.97687 | 6 | 16 | 734 | response to organic cyclic compound |
| GO:0043085 | 0.00025 | 2.61775 | 8 | 20 | 1051 | positive regulation of catalytic activity |
| GO:0071559 | 0.00025 | 5.21760 | 2 | 8 | 208 | response to transforming growth factor beta |
| GO:0046631 | 0.00025 | 6.06587 | 1 | 7 | 157 | alpha-beta T cell activation |
| GO:0030334 | 0.00026 | 2.76509 | 7 | 18 | 892 | regulation of cell migration |
| GO:0097755 | 0.00026 | 9.62603 | 1 | 5 | 72 | positive regulation of blood vessel diameter |
| GO:0001892 | 0.00027 | 7.33003 | 1 | 6 | 112 | embryonic placenta development |
| GO:0046632 | 0.00027 | 7.33003 | 1 | 6 | 112 | alpha-beta T cell differentiation |
| GO:0002369 | 0.00027 | 14.27126 | 0 | 4 | 40 | T cell cytokine production |
| GO:0050890 | 0.00028 | 4.15435 | 3 | 10 | 326 | cognition |
| GO:0044057 | 0.00029 | 3.19476 | 5 | 14 | 596 | regulation of system process |
| GO:0009913 | 0.00030 | 5.08923 | 2 | 8 | 213 | epidermal cell differentiation |
| GO:0046627 | 0.00030 | 13.88495 | 0 | 4 | 41 | negative regulation of insulin receptor signaling pathway |
| GO:0009314 | 0.00032 | 3.77109 | 3 | 11 | 395 | response to radiation |
| GO:0097190 | 0.00033 | 3.14485 | 5 | 14 | 605 | apoptotic signaling pathway |
| GO:0022603 | 0.00034 | 2.55287 | 8 | 20 | 1076 | regulation of anatomical structure morphogenesis |
| GO:0007179 | 0.00034 | 5.75672 | 1 | 7 | 165 | transforming growth factor beta receptor signaling pathway |
| GO:0030099 | 0.00036 | 3.71209 | 3 | 11 | 401 | myeloid cell differentiation |
| GO:0032729 | 0.00036 | 8.95560 | 1 | 5 | 77 | positive regulation of interferon-gamma production |
| GO:0071277 | 0.00036 | 8.95560 | 1 | 5 | 77 | cellular response to calcium ion |
| GO:0060416 | 0.00036 | 25.56889 | 0 | 3 | 18 | response to growth hormone |
| GO:0090090 | 0.00037 | 6.87386 | 1 | 6 | 119 | negative regulation of canonical Wnt signaling pathway |
| GO:0030097 | 0.00038 | 2.67279 | 7 | 18 | 921 | hemopoiesis |
| GO:0061138 | 0.00038 | 4.89636 | 2 | 8 | 221 | morphogenesis of a branching epithelium |
| GO:1902107 | 0.00038 | 5.64872 | 1 | 7 | 168 | positive regulation of leukocyte differentiation |
| GO:0071902 | 0.00039 | 4.35958 | 2 | 9 | 279 | positive regulation of protein serine/threonine kinase activity |
| GO:0070997 | 0.00039 | 3.67375 | 3 | 11 | 405 | neuron death |
| GO:0001890 | 0.00041 | 5.57892 | 1 | 7 | 170 | placenta development |
| GO:0009636 | 0.00042 | 3.92735 | 3 | 10 | 344 | response to toxic substance |
| GO:1900077 | 0.00043 | 12.52814 | 0 | 4 | 45 | negative regulation of cellular response to insulin stimulus |
| GO:0040012 | 0.00045 | 2.55458 | 8 | 19 | 1018 | regulation of locomotion |
| GO:0035296 | 0.00046 | 5.47738 | 1 | 7 | 173 | regulation of tube diameter |
| GO:0050880 | 0.00046 | 5.47738 | 1 | 7 | 173 | regulation of blood vessel size |
| GO:0097746 | 0.00046 | 5.47738 | 1 | 7 | 173 | regulation of blood vessel diameter |
| GO:0002009 | 0.00047 | 3.18443 | 4 | 13 | 553 | morphogenesis of an epithelium |
| GO:2001233 | 0.00047 | 3.59028 | 3 | 11 | 414 | regulation of apoptotic signaling pathway |
| GO:0035150 | 0.00047 | 5.44434 | 1 | 7 | 174 | regulation of tube size |
| GO:0002718 | 0.00048 | 8.37225 | 1 | 5 | 82 | regulation of cytokine production involved in immune response |
| GO:0008015 | 0.00048 | 3.35340 | 4 | 12 | 484 | blood circulation |
| GO:0009612 | 0.00051 | 5.37944 | 1 | 7 | 176 | response to mechanical stimulus |
| GO:0051592 | 0.00052 | 6.41715 | 1 | 6 | 127 | response to calcium ion |
| GO:0030278 | 0.00054 | 4.63279 | 2 | 8 | 233 | regulation of ossification |
| GO:0045930 | 0.00054 | 4.63279 | 2 | 8 | 233 | negative regulation of mitotic cell cycle |
| GO:0042110 | 0.00055 | 3.30337 | 4 | 12 | 491 | T cell activation |
| GO:0048598 | 0.00055 | 2.97906 | 5 | 14 | 637 | embryonic morphogenesis |
| GO:0032731 | 0.00055 | 11.67242 | 0 | 4 | 48 | positive regulation of interleukin-1 beta production |
| GO:0007178 | 0.00056 | 3.77805 | 3 | 10 | 357 | transmembrane receptor protein serine/threonine kinase signaling pathway |
| GO:0010035 | 0.00057 | 3.28935 | 4 | 12 | 493 | response to inorganic substance |
| GO:0007517 | 0.00057 | 3.50180 | 3 | 11 | 424 | muscle organ development |
| GO:0022414 | 0.00057 | 2.25111 | 12 | 24 | 1471 | reproductive process |
| GO:0000003 | 0.00058 | 2.24945 | 12 | 24 | 1472 | reproduction |
| GO:0001957 | 0.00061 | 84.80295 | 0 | 2 | 5 | intramembranous ossification |
| GO:0036072 | 0.00061 | 84.80295 | 0 | 2 | 5 | direct ossification |
| GO:0098609 | 0.00061 | 2.82700 | 6 | 15 | 720 | cell-cell adhesion |
| GO:2001235 | 0.00064 | 5.16390 | 1 | 7 | 183 | positive regulation of apoptotic signaling pathway |
| GO:0032330 | 0.00065 | 11.16395 | 0 | 4 | 50 | regulation of chondrocyte differentiation |
| GO:0001763 | 0.00066 | 4.49163 | 2 | 8 | 240 | morphogenesis of a branching structure |
| GO:0035914 | 0.00067 | 7.76499 | 1 | 5 | 88 | skeletal muscle cell differentiation |
| GO:0048699 | 0.00068 | 2.15116 | 13 | 26 | 1672 | generation of neurons |
| GO:0002694 | 0.00069 | 2.90707 | 5 | 14 | 652 | regulation of leukocyte activation |
| GO:0022409 | 0.00070 | 4.45284 | 2 | 8 | 242 | positive regulation of cell-cell adhesion |
| GO:0043618 | 0.00070 | 10.92595 | 0 | 4 | 51 | regulation of transcription from RNA polymerase II promoter in response to stress |
| GO:0008284 | 0.00070 | 2.52407 | 8 | 18 | 972 | positive regulation of cell proliferation |
| GO:0030182 | 0.00071 | 2.21353 | 12 | 24 | 1494 | neuron differentiation |
| GO:0042493 | 0.00074 | 2.58651 | 7 | 17 | 894 | response to drug |
| GO:0070372 | 0.00075 | 3.95855 | 2 | 9 | 306 | regulation of ERK1 and ERK2 cascade |
| GO:0010720 | 0.00077 | 2.87462 | 5 | 14 | 659 | positive regulation of cell development |
| GO:0071695 | 0.00080 | 4.96485 | 1 | 7 | 190 | anatomical structure maturation |
| GO:0032147 | 0.00082 | 4.34038 | 2 | 8 | 248 | activation of protein kinase activity |
| GO:0042592 | 0.00087 | 2.05696 | 15 | 28 | 1887 | homeostatic process |
| GO:0035272 | 0.00087 | 10.26905 | 0 | 4 | 54 | exocrine system development |
| GO:0032870 | 0.00087 | 3.12336 | 4 | 12 | 518 | cellular response to hormone stimulus |
| GO:0002709 | 0.00090 | 7.23962 | 1 | 5 | 94 | regulation of T cell mediated immunity |
| GO:0010273 | 0.00091 | 63.59945 | 0 | 2 | 6 | detoxification of copper ion |
| GO:0014043 | 0.00091 | 63.59945 | 0 | 2 | 6 | negative regulation of neuron maturation |
| GO:0051138 | 0.00091 | 63.59945 | 0 | 2 | 6 | positive regulation of NK T cell differentiation |
| GO:1990169 | 0.00091 | 63.59945 | 0 | 2 | 6 | stress response to copper ion |
| GO:0014706 | 0.00091 | 3.29828 | 4 | 11 | 449 | striated muscle tissue development |
| GO:0048608 | 0.00091 | 3.29828 | 4 | 11 | 449 | reproductive structure development |
| GO:0051046 | 0.00091 | 2.53538 | 7 | 17 | 911 | regulation of secretion |
| GO:0007266 | 0.00093 | 4.83175 | 2 | 7 | 195 | Rho protein signal transduction |
| GO:1903530 | 0.00093 | 2.61116 | 7 | 16 | 831 | regulation of secretion by cell |
| GO:0045667 | 0.00093 | 5.70563 | 1 | 6 | 142 | regulation of osteoblast differentiation |
| GO:0045582 | 0.00094 | 7.15886 | 1 | 5 | 95 | positive regulation of T cell differentiation |
| GO:0035024 | 0.00098 | 17.42803 | 0 | 3 | 25 | negative regulation of Rho protein signal transduction |
| GO:0061458 | 0.00098 | 3.26785 | 4 | 11 | 453 | reproductive system development |
| GO:1901652 | 0.00098 | 3.50113 | 3 | 10 | 384 | response to peptide |
| GO:0007519 | 0.00099 | 4.78047 | 2 | 7 | 197 | skeletal muscle tissue development |
| GO:0032732 | 0.00100 | 9.87323 | 0 | 4 | 56 | positive regulation of interleukin-1 production |
| GO:0043620 | 0.00100 | 9.87323 | 0 | 4 | 56 | regulation of DNA-templated transcription in response to stress |
| GO:0007159 | 0.00101 | 3.79038 | 3 | 9 | 319 | leukocyte cell-cell adhesion |
| GO:0018108 | 0.00101 | 3.79038 | 3 | 9 | 319 | peptidyl-tyrosine phosphorylation |
| GO:0009887 | 0.00103 | 2.37505 | 9 | 19 | 1090 | animal organ morphogenesis |
| GO:0033036 | 0.00106 | 1.84574 | 23 | 38 | 2901 | macromolecule localization |
| GO:0001501 | 0.00106 | 3.04938 | 4 | 12 | 530 | skeletal system development |
| GO:0018212 | 0.00108 | 3.75355 | 3 | 9 | 322 | peptidyl-tyrosine modification |
| GO:0007263 | 0.00110 | 16.66957 | 0 | 3 | 26 | nitric oxide mediated signal transduction |
| GO:0070371 | 0.00110 | 3.74143 | 3 | 9 | 323 | ERK1 and ERK2 cascade |
| GO:0043434 | 0.00112 | 3.72939 | 3 | 9 | 324 | response to peptide hormone |
| GO:0060443 | 0.00114 | 9.50672 | 0 | 4 | 58 | mammary gland morphogenesis |
| GO:0001701 | 0.00121 | 3.00193 | 4 | 12 | 538 | in utero embryonic development |
| GO:0046639 | 0.00123 | 15.97431 | 0 | 3 | 27 | negative regulation of alpha-beta T cell differentiation |
| GO:0022612 | 0.00124 | 5.38677 | 1 | 6 | 150 | gland morphogenesis |
| GO:0045580 | 0.00124 | 5.38677 | 1 | 6 | 150 | regulation of T cell differentiation |
| GO:0050865 | 0.00124 | 2.72653 | 5 | 14 | 693 | regulation of cell activation |
| GO:0001654 | 0.00126 | 3.38158 | 3 | 10 | 397 | eye development |
| GO:1900747 | 0.00127 | 50.87735 | 0 | 2 | 7 | negative regulation of vascular endothelial growth factor signaling pathway |
| GO:1903223 | 0.00127 | 50.87735 | 0 | 2 | 7 | positive regulation of oxidative stress-induced neuron death |
| GO:0060538 | 0.00128 | 4.56247 | 2 | 7 | 206 | skeletal muscle organ development |
| GO:0002367 | 0.00130 | 6.64022 | 1 | 5 | 102 | cytokine production involved in immune response |
| GO:0051130 | 0.00132 | 2.22260 | 10 | 21 | 1290 | positive regulation of cellular component organization |
| GO:0150063 | 0.00133 | 3.35512 | 3 | 10 | 400 | visual system development |
| GO:0002682 | 0.00135 | 2.13910 | 12 | 23 | 1473 | regulation of immune system process |
| GO:1903708 | 0.00135 | 4.51668 | 2 | 7 | 208 | positive regulation of hemopoiesis |
| GO:0060537 | 0.00136 | 3.13053 | 4 | 11 | 472 | muscle tissue development |
| GO:0035162 | 0.00137 | 15.33467 | 0 | 3 | 28 | embryonic hemopoiesis |
| GO:0035335 | 0.00137 | 15.33467 | 0 | 3 | 28 | peptidyl-tyrosine dephosphorylation |
| GO:0030217 | 0.00137 | 3.98748 | 2 | 8 | 269 | T cell differentiation |
| GO:0045600 | 0.00137 | 9.00519 | 0 | 4 | 61 | positive regulation of fat cell differentiation |
| GO:0048880 | 0.00141 | 3.32907 | 3 | 10 | 403 | sensory system development |
| GO:0030030 | 0.00143 | 2.09439 | 12 | 24 | 1572 | cell projection organization |
| GO:0051216 | 0.00147 | 4.44967 | 2 | 7 | 211 | cartilage development |
| GO:0032880 | 0.00148 | 2.35369 | 8 | 18 | 1038 | regulation of protein localization |
| GO:0001667 | 0.00149 | 3.30341 | 3 | 10 | 406 | ameboidal-type cell migration |
| GO:0033687 | 0.00152 | 14.74423 | 0 | 3 | 29 | osteoblast proliferation |
| GO:0071548 | 0.00152 | 14.74423 | 0 | 3 | 29 | response to dexamethasone |
| GO:0050767 | 0.00153 | 2.40897 | 8 | 17 | 956 | regulation of neurogenesis |
| GO:0003006 | 0.00156 | 2.56018 | 6 | 15 | 791 | developmental process involved in reproduction |
| GO:0033135 | 0.00156 | 5.13548 | 1 | 6 | 157 | regulation of peptidyl-serine phosphorylation |
| GO:0048666 | 0.00162 | 2.22788 | 10 | 20 | 1222 | neuron development |
| GO:0009880 | 0.00164 | 8.55382 | 1 | 4 | 64 | embryonic pattern specification |
| GO:2000514 | 0.00164 | 8.55382 | 1 | 4 | 64 | regulation of CD4-positive, alpha-beta T cell activation |
| GO:0045621 | 0.00167 | 6.25177 | 1 | 5 | 108 | positive regulation of lymphocyte differentiation |
| GO:0018193 | 0.00167 | 2.27034 | 9 | 19 | 1137 | peptidyl-amino acid modification |
| GO:0042045 | 0.00168 | 42.39595 | 0 | 2 | 8 | epithelial fluid transport |
| GO:0045360 | 0.00168 | 42.39595 | 0 | 2 | 8 | regulation of interleukin-1 biosynthetic process |
| GO:0045362 | 0.00168 | 42.39595 | 0 | 2 | 8 | positive regulation of interleukin-1 biosynthetic process |
| GO:0051136 | 0.00168 | 42.39595 | 0 | 2 | 8 | regulation of NK T cell differentiation |
| GO:0061687 | 0.00168 | 42.39595 | 0 | 2 | 8 | detoxification of inorganic compound |
| GO:0072126 | 0.00168 | 42.39595 | 0 | 2 | 8 | positive regulation of glomerular mesangial cell proliferation |
| GO:0097501 | 0.00168 | 42.39595 | 0 | 2 | 8 | stress response to metal ion |
| GO:1902548 | 0.00168 | 42.39595 | 0 | 2 | 8 | negative regulation of cellular response to vascular endothelial growth factor stimulus |
| GO:0046903 | 0.00170 | 2.21814 | 10 | 20 | 1227 | secretion |
| GO:0048871 | 0.00171 | 3.03638 | 4 | 11 | 486 | multicellular organismal homeostasis |
| GO:0090066 | 0.00172 | 2.87323 | 4 | 12 | 561 | regulation of anatomical structure size |
| GO:0032649 | 0.00174 | 6.19139 | 1 | 5 | 109 | regulation of interferon-gamma production |
| GO:0030968 | 0.00174 | 8.41322 | 1 | 4 | 65 | endoplasmic reticulum unfolded protein response |
| GO:0033627 | 0.00174 | 8.41322 | 1 | 4 | 65 | cell adhesion mediated by integrin |
| GO:0001655 | 0.00176 | 3.48255 | 3 | 9 | 346 | urogenital system development |
| GO:0050708 | 0.00183 | 3.01049 | 4 | 11 | 490 | regulation of protein secretion |
| GO:0043010 | 0.00183 | 3.46170 | 3 | 9 | 348 | camera-type eye development |
| GO:0050718 | 0.00184 | 13.68988 | 0 | 3 | 31 | positive regulation of interleukin-1 beta secretion |
| GO:0007417 | 0.00185 | 2.43421 | 7 | 16 | 888 | central nervous system development |
| GO:0043406 | 0.00186 | 4.25998 | 2 | 7 | 220 | positive regulation of MAP kinase activity |
| GO:0001942 | 0.00188 | 6.07404 | 1 | 5 | 111 | hair follicle development |
| GO:0030879 | 0.00189 | 4.93793 | 1 | 6 | 163 | mammary gland development |
| GO:0007346 | 0.00192 | 2.99135 | 4 | 11 | 493 | regulation of mitotic cell cycle |
| GO:0007162 | 0.00193 | 3.76828 | 2 | 8 | 284 | negative regulation of cell adhesion |
| GO:0007610 | 0.00196 | 2.58882 | 6 | 14 | 728 | behavior |
| GO:0060561 | 0.00202 | 13.21724 | 0 | 3 | 32 | apoptotic process involved in morphogenesis |
| GO:0098773 | 0.00204 | 5.96104 | 1 | 5 | 113 | skin epidermis development |
| GO:0080134 | 0.00204 | 2.13859 | 11 | 21 | 1337 | regulation of response to stress |
| GO:0051962 | 0.00204 | 2.68354 | 5 | 13 | 651 | positive regulation of nervous system development |
| GO:0045669 | 0.00206 | 8.01781 | 1 | 4 | 68 | positive regulation of osteoblast differentiation |
| GO:1903037 | 0.00206 | 3.72727 | 2 | 8 | 287 | regulation of leukocyte cell-cell adhesion |
| GO:0032940 | 0.00206 | 2.27878 | 8 | 18 | 1070 | secretion by cell |
| GO:0051960 | 0.00208 | 2.27651 | 8 | 18 | 1071 | regulation of nervous system development |
| GO:0031331 | 0.00210 | 3.39062 | 3 | 9 | 355 | positive regulation of cellular catabolic process |
| GO:0002684 | 0.00210 | 2.27425 | 8 | 18 | 1072 | positive regulation of immune system process |
| GO:0022404 | 0.00212 | 5.90609 | 1 | 5 | 114 | molting cycle process |
| GO:0022405 | 0.00212 | 5.90609 | 1 | 5 | 114 | hair cycle process |
| GO:0035878 | 0.00215 | 36.33781 | 0 | 2 | 9 | nail development |
| GO:0042222 | 0.00215 | 36.33781 | 0 | 2 | 9 | interleukin-1 biosynthetic process |
| GO:0048102 | 0.00215 | 36.33781 | 0 | 2 | 9 | autophagic cell death |
| GO:0043407 | 0.00217 | 7.89411 | 1 | 4 | 69 | negative regulation of MAP kinase activity |
| GO:0061035 | 0.00217 | 7.89411 | 1 | 4 | 69 | regulation of cartilage development |
| GO:0014741 | 0.00221 | 12.77611 | 0 | 3 | 33 | negative regulation of muscle hypertrophy |
| GO:1904467 | 0.00221 | 12.77611 | 0 | 3 | 33 | regulation of tumor necrosis factor secretion |
| GO:0050769 | 0.00226 | 2.77477 | 5 | 12 | 580 | positive regulation of neurogenesis |
| GO:0097191 | 0.00233 | 4.08566 | 2 | 7 | 229 | extrinsic apoptotic signaling pathway |
| GO:0007369 | 0.00234 | 4.72571 | 1 | 6 | 170 | gastrulation |
| GO:1902105 | 0.00239 | 3.63493 | 2 | 8 | 294 | regulation of leukocyte differentiation |
| GO:0007612 | 0.00241 | 4.69687 | 1 | 6 | 171 | learning |
| GO:0042733 | 0.00241 | 7.65780 | 1 | 4 | 71 | embryonic digit morphogenesis |
| GO:0050716 | 0.00241 | 12.36344 | 0 | 3 | 34 | positive regulation of interleukin-1 secretion |
| GO:2000241 | 0.00248 | 4.66837 | 1 | 6 | 172 | regulation of reproductive process |
| GO:0000079 | 0.00253 | 7.54486 | 1 | 4 | 72 | regulation of cyclin-dependent protein serine/threonine kinase activity |
| GO:1902533 | 0.00259 | 2.28442 | 8 | 17 | 1005 | positive regulation of intracellular signal transduction |
| GO:1990774 | 0.00262 | 11.97656 | 0 | 3 | 35 | tumor necrosis factor secretion |
| GO:1901216 | 0.00265 | 5.59648 | 1 | 5 | 120 | positive regulation of neuron death |
| GO:0043651 | 0.00267 | 31.79420 | 0 | 2 | 10 | linoleic acid metabolic process |
| GO:1901724 | 0.00267 | 31.79420 | 0 | 2 | 10 | positive regulation of cell proliferation involved in kidney development |
| GO:0001775 | 0.00272 | 2.21687 | 9 | 18 | 1098 | cell activation |
| GO:0008202 | 0.00276 | 3.54699 | 2 | 8 | 301 | steroid metabolic process |
| GO:0000902 | 0.00277 | 2.21257 | 9 | 18 | 1100 | cell morphogenesis |
| GO:0032651 | 0.00280 | 7.32865 | 1 | 4 | 74 | regulation of interleukin-1 beta production |
| GO:0097327 | 0.00280 | 7.32865 | 1 | 4 | 74 | response to antineoplastic agent |
| GO:0072001 | 0.00282 | 3.53477 | 2 | 8 | 302 | renal system development |
| GO:0032609 | 0.00284 | 5.50034 | 1 | 5 | 122 | interferon-gamma production |
| GO:0043410 | 0.00285 | 2.83498 | 4 | 11 | 519 | positive regulation of MAPK cascade |
| GO:0001817 | 0.00293 | 2.56751 | 5 | 13 | 679 | regulation of cytokine production |
| GO:0046626 | 0.00294 | 7.22512 | 1 | 4 | 75 | regulation of insulin receptor signaling pathway |
| GO:0001659 | 0.00302 | 4.47810 | 1 | 6 | 179 | temperature homeostasis |
| GO:0002053 | 0.00308 | 11.27108 | 0 | 3 | 37 | positive regulation of mesenchymal cell proliferation |
| GO:0060674 | 0.00308 | 11.27108 | 0 | 3 | 37 | placenta blood vessel development |
| GO:1904029 | 0.00308 | 7.12446 | 1 | 4 | 76 | regulation of cyclin-dependent protein kinase activity |
| GO:0001819 | 0.00309 | 2.97418 | 4 | 10 | 449 | positive regulation of cytokine production |
| GO:0009306 | 0.00318 | 2.65483 | 5 | 12 | 605 | protein secretion |
| GO:0051047 | 0.00320 | 2.79003 | 4 | 11 | 527 | positive regulation of secretion |
| GO:0001865 | 0.00325 | 28.26028 | 0 | 2 | 11 | NK T cell differentiation |
| GO:0002664 | 0.00325 | 28.26028 | 0 | 2 | 11 | regulation of T cell tolerance induction |
| GO:0070601 | 0.00325 | 28.26028 | 0 | 2 | 11 | centromeric sister chromatid cohesion |
| GO:1990440 | 0.00325 | 28.26028 | 0 | 2 | 11 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress |
| GO:0008203 | 0.00327 | 5.31758 | 1 | 5 | 126 | cholesterol metabolic process |
| GO:0045619 | 0.00328 | 4.40119 | 1 | 6 | 182 | regulation of lymphocyte differentiation |
| GO:0002791 | 0.00329 | 2.77901 | 4 | 11 | 529 | regulation of peptide secretion |
| GO:0060562 | 0.00330 | 3.15866 | 3 | 9 | 380 | epithelial tube morphogenesis |
| GO:1901215 | 0.00331 | 3.82456 | 2 | 7 | 244 | negative regulation of neuron death |
| GO:0000578 | 0.00332 | 10.94857 | 0 | 3 | 38 | embryonic axis specification |
| GO:0030851 | 0.00332 | 10.94857 | 0 | 3 | 38 | granulocyte differentiation |
| GO:0008104 | 0.00344 | 1.77055 | 20 | 33 | 2578 | protein localization |
| GO:0048754 | 0.00346 | 4.35136 | 1 | 6 | 184 | branching morphogenesis of an epithelial tube |
| GO:0045664 | 0.00349 | 2.42052 | 6 | 14 | 776 | regulation of neuron differentiation |
| GO:0071396 | 0.00349 | 2.62304 | 5 | 12 | 612 | cellular response to lipid |
| GO:0071216 | 0.00350 | 3.40564 | 2 | 8 | 313 | cellular response to biotic stimulus |
| GO:0044087 | 0.00352 | 2.27134 | 7 | 16 | 948 | regulation of cellular component biogenesis |
| GO:0045766 | 0.00355 | 4.32686 | 1 | 6 | 185 | positive regulation of angiogenesis |
| GO:0008207 | 0.00358 | 10.64398 | 0 | 3 | 39 | C21-steroid hormone metabolic process |
| GO:0050870 | 0.00374 | 4.27868 | 1 | 6 | 187 | positive regulation of T cell activation |
| GO:0002703 | 0.00378 | 3.72914 | 2 | 7 | 250 | regulation of leukocyte mediated immunity |
| GO:0050706 | 0.00384 | 10.35586 | 0 | 3 | 40 | regulation of interleukin-1 beta secretion |
| GO:0048562 | 0.00385 | 3.34997 | 3 | 8 | 318 | embryonic organ morphogenesis |
| GO:0042303 | 0.00386 | 5.10545 | 1 | 5 | 131 | molting cycle |
| GO:0042633 | 0.00386 | 5.10545 | 1 | 5 | 131 | hair cycle |
| GO:1902652 | 0.00386 | 5.10545 | 1 | 5 | 131 | secondary alcohol metabolic process |
| GO:0070423 | 0.00387 | 25.43315 | 0 | 2 | 12 | nucleotide-binding oligomerization domain containing signaling pathway |
| GO:0070431 | 0.00387 | 25.43315 | 0 | 2 | 12 | nucleotide-binding oligomerization domain containing 2 signaling pathway |
| GO:0071294 | 0.00387 | 25.43315 | 0 | 2 | 12 | cellular response to zinc ion |
| GO:0072124 | 0.00387 | 25.43315 | 0 | 2 | 12 | regulation of glomerular mesangial cell proliferation |
| GO:2000243 | 0.00388 | 6.66038 | 1 | 4 | 81 | positive regulation of reproductive process |
| GO:0002822 | 0.00394 | 4.23155 | 1 | 6 | 189 | regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0034620 | 0.00405 | 6.57470 | 1 | 4 | 82 | cellular response to unfolded protein |
| GO:0007431 | 0.00412 | 10.08289 | 0 | 3 | 41 | salivary gland development |
| GO:0051223 | 0.00417 | 2.45718 | 6 | 13 | 708 | regulation of protein transport |
| GO:0030855 | 0.00417 | 2.56163 | 5 | 12 | 626 | epithelial cell differentiation |
| GO:0033045 | 0.00423 | 6.49120 | 1 | 4 | 83 | regulation of sister chromatid segregation |
| GO:0097581 | 0.00423 | 6.49120 | 1 | 4 | 83 | lamellipodium organization |
| GO:0055123 | 0.00425 | 4.98606 | 1 | 5 | 134 | digestive system development |
| GO:0022407 | 0.00425 | 3.03390 | 3 | 9 | 395 | regulation of cell-cell adhesion |
| GO:0016125 | 0.00438 | 4.94749 | 1 | 5 | 135 | sterol metabolic process |
| GO:0035023 | 0.00438 | 4.94749 | 1 | 5 | 135 | regulation of Rho protein signal transduction |
| GO:0045598 | 0.00438 | 4.94749 | 1 | 5 | 135 | regulation of fat cell differentiation |
| GO:1903532 | 0.00439 | 2.82324 | 4 | 10 | 472 | positive regulation of secretion by cell |
| GO:0046636 | 0.00442 | 9.82393 | 0 | 3 | 42 | negative regulation of alpha-beta T cell activation |
| GO:1902742 | 0.00442 | 9.82393 | 0 | 3 | 42 | apoptotic process involved in development |
| GO:1902743 | 0.00442 | 9.82393 | 0 | 3 | 42 | regulation of lamellipodium organization |
| GO:0098813 | 0.00449 | 3.60902 | 2 | 7 | 258 | nuclear chromosome segregation |
| GO:0120036 | 0.00451 | 1.95547 | 12 | 22 | 1526 | plasma membrane bounded cell projection organization |
| GO:0002517 | 0.00455 | 23.12004 | 0 | 2 | 13 | T cell tolerance induction |
| GO:0035872 | 0.00455 | 23.12004 | 0 | 2 | 13 | nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway |
| GO:0060670 | 0.00455 | 23.12004 | 0 | 2 | 13 | branching involved in labyrinthine layer morphogenesis |
| GO:0072110 | 0.00455 | 23.12004 | 0 | 2 | 13 | glomerular mesangial cell proliferation |
| GO:0090193 | 0.00455 | 23.12004 | 0 | 2 | 13 | positive regulation of glomerulus development |
| GO:2000833 | 0.00455 | 23.12004 | 0 | 2 | 13 | positive regulation of steroid hormone secretion |
| GO:0051384 | 0.00461 | 6.33037 | 1 | 4 | 85 | response to glucocorticoid |
| GO:0002456 | 0.00466 | 4.87211 | 1 | 5 | 137 | T cell mediated immunity |
| GO:0048593 | 0.00466 | 4.87211 | 1 | 5 | 137 | camera-type eye morphogenesis |
| GO:0051249 | 0.00470 | 2.64314 | 4 | 11 | 555 | regulation of lymphocyte activation |
| GO:0048246 | 0.00472 | 9.57792 | 0 | 3 | 43 | macrophage chemotaxis |
| GO:0032611 | 0.00480 | 6.25290 | 1 | 4 | 86 | interleukin-1 beta production |
| GO:0007050 | 0.00481 | 4.83526 | 1 | 5 | 138 | cell cycle arrest |
| GO:0010817 | 0.00483 | 2.63322 | 4 | 11 | 557 | regulation of hormone levels |
| GO:0050730 | 0.00498 | 3.53775 | 2 | 7 | 263 | regulation of peptidyl-tyrosine phosphorylation |
| GO:0051898 | 0.00504 | 9.34390 | 0 | 3 | 44 | negative regulation of protein kinase B signaling |
| GO:0071385 | 0.00504 | 9.34390 | 0 | 3 | 44 | cellular response to glucocorticoid stimulus |
| GO:0030522 | 0.00506 | 4.01054 | 2 | 6 | 199 | intracellular receptor signaling pathway |
| GO:0043523 | 0.00508 | 3.52383 | 2 | 7 | 264 | regulation of neuron apoptotic process |
| GO:1903706 | 0.00515 | 2.94087 | 3 | 9 | 407 | regulation of hemopoiesis |
| GO:1903047 | 0.00521 | 2.48668 | 5 | 12 | 644 | mitotic cell cycle process |
| GO:0032642 | 0.00521 | 6.10348 | 1 | 4 | 88 | regulation of chemokine production |
| GO:0030950 | 0.00529 | 21.19245 | 0 | 2 | 14 | establishment or maintenance of actin cytoskeleton polarity |
| GO:1905941 | 0.00529 | 21.19245 | 0 | 2 | 14 | positive regulation of gonad development |
| GO:0048736 | 0.00530 | 3.96906 | 2 | 6 | 201 | appendage development |
| GO:0060173 | 0.00530 | 3.96906 | 2 | 6 | 201 | limb development |
| GO:0010464 | 0.00537 | 9.12103 | 0 | 3 | 45 | regulation of mesenchymal cell proliferation |
| GO:0050974 | 0.00537 | 9.12103 | 0 | 3 | 45 | detection of mechanical stimulus involved in sensory perception |
| GO:0007229 | 0.00542 | 6.03142 | 1 | 4 | 89 | integrin-mediated signaling pathway |
| GO:0031960 | 0.00542 | 6.03142 | 1 | 4 | 89 | response to corticosteroid |
| GO:1900076 | 0.00542 | 6.03142 | 1 | 4 | 89 | regulation of cellular response to insulin stimulus |
| GO:0045785 | 0.00548 | 2.91109 | 3 | 9 | 411 | positive regulation of cell adhesion |
| GO:0045321 | 0.00552 | 2.16000 | 8 | 16 | 994 | leukocyte activation |
| GO:1903039 | 0.00556 | 3.92842 | 2 | 6 | 203 | positive regulation of leukocyte cell-cell adhesion |
| GO:0030326 | 0.00558 | 4.65905 | 1 | 5 | 143 | embryonic limb morphogenesis |
| GO:0035113 | 0.00558 | 4.65905 | 1 | 5 | 143 | embryonic appendage morphogenesis |
| GO:0090288 | 0.00558 | 4.65905 | 1 | 5 | 143 | negative regulation of cellular response to growth factor stimulus |
| GO:0032757 | 0.00571 | 8.90853 | 0 | 3 | 46 | positive regulation of interleukin-8 production |
| GO:0071384 | 0.00571 | 8.90853 | 0 | 3 | 46 | cellular response to corticosteroid stimulus |
| GO:0002790 | 0.00573 | 2.45471 | 5 | 12 | 652 | peptide secretion |
| GO:0007613 | 0.00575 | 4.62533 | 1 | 5 | 144 | memory |
| GO:0048878 | 0.00583 | 2.04902 | 9 | 18 | 1182 | chemical homeostasis |
| GO:0002819 | 0.00583 | 3.88860 | 2 | 6 | 205 | regulation of adaptive immune response |
| GO:0032652 | 0.00587 | 5.89225 | 1 | 4 | 91 | regulation of interleukin-1 production |
| GO:0034329 | 0.00596 | 3.86898 | 2 | 6 | 206 | cell junction assembly |
| GO:0070201 | 0.00599 | 2.34566 | 6 | 13 | 740 | regulation of establishment of protein localization |
| GO:0018209 | 0.00602 | 3.09656 | 3 | 8 | 343 | peptidyl-serine modification |
| GO:0033046 | 0.00606 | 8.70568 | 0 | 3 | 47 | negative regulation of sister chromatid segregation |
| GO:0045581 | 0.00606 | 8.70568 | 0 | 3 | 47 | negative regulation of T cell differentiation |
| GO:0050702 | 0.00606 | 8.70568 | 0 | 3 | 47 | interleukin-1 beta secretion |
| GO:0050704 | 0.00606 | 8.70568 | 0 | 3 | 47 | regulation of interleukin-1 secretion |
| GO:0120163 | 0.00606 | 8.70568 | 0 | 3 | 47 | negative regulation of cold-induced thermogenesis |
| GO:1902041 | 0.00606 | 8.70568 | 0 | 3 | 47 | regulation of extrinsic apoptotic signaling pathway via death domain receptors |
| GO:0048385 | 0.00607 | 19.56141 | 0 | 2 | 15 | regulation of retinoic acid receptor signaling pathway |
| GO:0051044 | 0.00607 | 19.56141 | 0 | 2 | 15 | positive regulation of membrane protein ectodomain proteolysis |
| GO:0060396 | 0.00607 | 19.56141 | 0 | 2 | 15 | growth hormone receptor signaling pathway |
| GO:0070102 | 0.00607 | 19.56141 | 0 | 2 | 15 | interleukin-6-mediated signaling pathway |
| GO:0071280 | 0.00607 | 19.56141 | 0 | 2 | 15 | cellular response to copper ion |
| GO:0071378 | 0.00607 | 19.56141 | 0 | 2 | 15 | cellular response to growth hormone stimulus |
| GO:0032602 | 0.00610 | 5.82504 | 1 | 4 | 92 | chemokine production |
| GO:0002697 | 0.00629 | 2.84621 | 3 | 9 | 420 | regulation of immune effector process |
| GO:0050873 | 0.00643 | 8.51185 | 0 | 3 | 48 | brown fat cell differentiation |
| GO:0002700 | 0.00644 | 4.49517 | 1 | 5 | 148 | regulation of production of molecular mediator of immune response |
| GO:0009896 | 0.00648 | 2.83218 | 3 | 9 | 422 | positive regulation of catabolic process |
| GO:0001570 | 0.00657 | 5.69510 | 1 | 4 | 94 | vasculogenesis |
| GO:0090087 | 0.00661 | 2.31604 | 6 | 13 | 749 | regulation of peptide transport |
| GO:0048839 | 0.00668 | 3.77379 | 2 | 6 | 211 | inner ear development |
| GO:0080135 | 0.00674 | 2.40067 | 5 | 12 | 666 | regulation of cellular response to stress |
| GO:0008360 | 0.00681 | 4.43278 | 1 | 5 | 150 | regulation of cell shape |
| GO:0042448 | 0.00690 | 18.16338 | 0 | 2 | 16 | progesterone metabolic process |
| GO:0070262 | 0.00690 | 18.16338 | 0 | 2 | 16 | peptidyl-serine dephosphorylation |
| GO:0072109 | 0.00690 | 18.16338 | 0 | 2 | 16 | glomerular mesangium development |
| GO:1901722 | 0.00690 | 18.16338 | 0 | 2 | 16 | regulation of cell proliferation involved in kidney development |
| GO:0010631 | 0.00694 | 3.31498 | 2 | 7 | 280 | epithelial cell migration |
| GO:0001816 | 0.00704 | 2.29669 | 6 | 13 | 755 | cytokine production |
| GO:0001822 | 0.00707 | 3.30273 | 2 | 7 | 281 | kidney development |
| GO:0043370 | 0.00720 | 8.14894 | 0 | 3 | 50 | regulation of CD4-positive, alpha-beta T cell differentiation |
| GO:0051985 | 0.00720 | 8.14894 | 0 | 3 | 50 | negative regulation of chromosome segregation |
| GO:0071675 | 0.00720 | 8.14894 | 0 | 3 | 50 | regulation of mononuclear cell migration |
| GO:0090132 | 0.00721 | 3.29058 | 2 | 7 | 282 | epithelium migration |
| GO:0032989 | 0.00741 | 1.99656 | 10 | 18 | 1211 | cellular component morphogenesis |
| GO:0048545 | 0.00746 | 3.68313 | 2 | 6 | 216 | response to steroid hormone |
| GO:0048762 | 0.00746 | 3.68313 | 2 | 6 | 216 | mesenchymal cell differentiation |
| GO:0044772 | 0.00746 | 2.97918 | 3 | 8 | 356 | mitotic cell cycle phase transition |
| GO:0090130 | 0.00748 | 3.26653 | 2 | 7 | 284 | tissue migration |
| GO:0071478 | 0.00759 | 4.31302 | 1 | 5 | 154 | cellular response to radiation |
| GO:0032355 | 0.00761 | 7.97882 | 0 | 3 | 51 | response to estradiol |
| GO:0090192 | 0.00778 | 16.95175 | 0 | 2 | 17 | regulation of glomerulus development |
| GO:1900746 | 0.00778 | 16.95175 | 0 | 2 | 17 | regulation of vascular endothelial growth factor signaling pathway |
| GO:0001987 | 0.00788 | Inf | 0 | 1 | 1 | vasoconstriction of artery involved in baroreceptor response to lowering of systemic arterial blood pressure |
| GO:0002539 | 0.00788 | Inf | 0 | 1 | 1 | prostaglandin production involved in inflammatory response |
| GO:0002651 | 0.00788 | Inf | 0 | 1 | 1 | positive regulation of tolerance induction to self antigen |
| GO:0003017 | 0.00788 | Inf | 0 | 1 | 1 | lymph circulation |
| GO:0007497 | 0.00788 | Inf | 0 | 1 | 1 | posterior midgut development |
| GO:0009810 | 0.00788 | Inf | 0 | 1 | 1 | stilbene metabolic process |
| GO:0022012 | 0.00788 | Inf | 0 | 1 | 1 | subpallium cell proliferation in forebrain |
| GO:0022018 | 0.00788 | Inf | 0 | 1 | 1 | lateral ganglionic eminence cell proliferation |
| GO:0035260 | 0.00788 | Inf | 0 | 1 | 1 | internal genitalia morphogenesis |
| GO:0035645 | 0.00788 | Inf | 0 | 1 | 1 | enteric smooth muscle cell differentiation |
| GO:0035935 | 0.00788 | Inf | 0 | 1 | 1 | androgen secretion |
| GO:0036496 | 0.00788 | Inf | 0 | 1 | 1 | regulation of translational initiation by eIF2 alpha dephosphorylation |
| GO:0036497 | 0.00788 | Inf | 0 | 1 | 1 | eIF2alpha dephosphorylation in response to endoplasmic reticulum stress |
| GO:0044324 | 0.00788 | Inf | 0 | 1 | 1 | regulation of transcription involved in anterior/posterior axis specification |
| GO:0046272 | 0.00788 | Inf | 0 | 1 | 1 | stilbene catabolic process |
| GO:0046687 | 0.00788 | Inf | 0 | 1 | 1 | response to chromate |
| GO:0048792 | 0.00788 | Inf | 0 | 1 | 1 | spontaneous exocytosis of neurotransmitter |
| GO:0060034 | 0.00788 | Inf | 0 | 1 | 1 | notochord cell differentiation |
| GO:0060035 | 0.00788 | Inf | 0 | 1 | 1 | notochord cell development |
| GO:0060366 | 0.00788 | Inf | 0 | 1 | 1 | lambdoid suture morphogenesis |
| GO:0060367 | 0.00788 | Inf | 0 | 1 | 1 | sagittal suture morphogenesis |
| GO:0060873 | 0.00788 | Inf | 0 | 1 | 1 | anterior semicircular canal development |
| GO:0060875 | 0.00788 | Inf | 0 | 1 | 1 | lateral semicircular canal development |
| GO:0070430 | 0.00788 | Inf | 0 | 1 | 1 | positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway |
| GO:0071228 | 0.00788 | Inf | 0 | 1 | 1 | cellular response to tumor cell |
| GO:0071247 | 0.00788 | Inf | 0 | 1 | 1 | cellular response to chromate |
| GO:0072303 | 0.00788 | Inf | 0 | 1 | 1 | positive regulation of glomerular metanephric mesangial cell proliferation |
| GO:0072702 | 0.00788 | Inf | 0 | 1 | 1 | response to methyl methanesulfonate |
| GO:0072703 | 0.00788 | Inf | 0 | 1 | 1 | cellular response to methyl methanesulfonate |
| GO:0097086 | 0.00788 | Inf | 0 | 1 | 1 | amniotic stem cell differentiation |
| GO:0106088 | 0.00788 | Inf | 0 | 1 | 1 | regulation of cell adhesion involved in sprouting angiogenesis |
| GO:0106089 | 0.00788 | Inf | 0 | 1 | 1 | negative regulation of cell adhesion involved in sprouting angiogenesis |
| GO:0110077 | 0.00788 | Inf | 0 | 1 | 1 | vesicle-mediated intercellular transport |
| GO:1900036 | 0.00788 | Inf | 0 | 1 | 1 | positive regulation of cellular response to heat |
| GO:1902161 | 0.00788 | Inf | 0 | 1 | 1 | positive regulation of cyclic nucleotide-gated ion channel activity |
| GO:1903769 | 0.00788 | Inf | 0 | 1 | 1 | negative regulation of cell proliferation in bone marrow |
| GO:1903916 | 0.00788 | Inf | 0 | 1 | 1 | regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation |
| GO:1903917 | 0.00788 | Inf | 0 | 1 | 1 | positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation |
| GO:1904806 | 0.00788 | Inf | 0 | 1 | 1 | regulation of protein oxidation |
| GO:1904808 | 0.00788 | Inf | 0 | 1 | 1 | positive regulation of protein oxidation |
| GO:1905317 | 0.00788 | Inf | 0 | 1 | 1 | inferior endocardial cushion morphogenesis |
| GO:2000077 | 0.00788 | Inf | 0 | 1 | 1 | negative regulation of type B pancreatic cell development |
| GO:2000706 | 0.00788 | Inf | 0 | 1 | 1 | negative regulation of dense core granule biogenesis |
| GO:2000797 | 0.00788 | Inf | 0 | 1 | 1 | regulation of amniotic stem cell differentiation |
| GO:2000798 | 0.00788 | Inf | 0 | 1 | 1 | negative regulation of amniotic stem cell differentiation |
| GO:2000834 | 0.00788 | Inf | 0 | 1 | 1 | regulation of androgen secretion |
| GO:2000836 | 0.00788 | Inf | 0 | 1 | 1 | positive regulation of androgen secretion |
| GO:1901653 | 0.00790 | 3.23111 | 2 | 7 | 287 | cellular response to peptide |
| GO:0030324 | 0.00796 | 3.63078 | 2 | 6 | 219 | lung development |
| GO:0006935 | 0.00797 | 2.44911 | 5 | 11 | 597 | chemotaxis |
| GO:0035924 | 0.00803 | 7.81565 | 0 | 3 | 52 | cellular response to vascular endothelial growth factor stimulus |
| GO:0035710 | 0.00815 | 5.33776 | 1 | 4 | 100 | CD4-positive, alpha-beta T cell activation |
| GO:0032101 | 0.00824 | 2.24967 | 6 | 13 | 770 | regulation of response to external stimulus |
| GO:0042330 | 0.00826 | 2.43631 | 5 | 11 | 600 | taxis |
| GO:0031098 | 0.00834 | 3.19643 | 2 | 7 | 290 | stress-activated protein kinase signaling cascade |
| GO:1903707 | 0.00843 | 4.19953 | 1 | 5 | 158 | negative regulation of hemopoiesis |
| GO:0042310 | 0.00843 | 5.28250 | 1 | 4 | 101 | vasoconstriction |
| GO:0090263 | 0.00843 | 5.28250 | 1 | 4 | 101 | positive regulation of canonical Wnt signaling pathway |
| GO:0002720 | 0.00846 | 7.65900 | 0 | 3 | 53 | positive regulation of cytokine production involved in immune response |
| GO:0009948 | 0.00846 | 7.65900 | 0 | 3 | 53 | anterior/posterior axis specification |
| GO:0030323 | 0.00848 | 3.57988 | 2 | 6 | 222 | respiratory tube development |
| GO:0046879 | 0.00861 | 2.90292 | 3 | 8 | 365 | hormone secretion |
| GO:0060322 | 0.00861 | 2.32025 | 5 | 12 | 688 | head development |
| GO:0031668 | 0.00866 | 3.56323 | 2 | 6 | 223 | cellular response to extracellular stimulus |
| GO:0006700 | 0.00871 | 15.89157 | 0 | 2 | 18 | C21-steroid hormone biosynthetic process |
| GO:0010566 | 0.00871 | 15.89157 | 0 | 2 | 18 | regulation of ketone biosynthetic process |
| GO:0014041 | 0.00871 | 15.89157 | 0 | 2 | 18 | regulation of neuron maturation |
| GO:0030952 | 0.00871 | 15.89157 | 0 | 2 | 18 | establishment or maintenance of cytoskeleton polarity |
| GO:0060712 | 0.00871 | 15.89157 | 0 | 2 | 18 | spongiotrophoblast layer development |
| GO:1902547 | 0.00871 | 15.89157 | 0 | 2 | 18 | regulation of cellular response to vascular endothelial growth factor stimulus |
| GO:1903209 | 0.00871 | 15.89157 | 0 | 2 | 18 | positive regulation of oxidative stress-induced cell death |
| GO:2000810 | 0.00871 | 15.89157 | 0 | 2 | 18 | regulation of bicellular tight junction assembly |
| GO:0023061 | 0.00879 | 2.53682 | 4 | 10 | 523 | signal release |
| GO:0051402 | 0.00880 | 3.16249 | 2 | 7 | 293 | neuron apoptotic process |
| GO:0009953 | 0.00902 | 5.17533 | 1 | 4 | 103 | dorsal/ventral pattern formation |
| GO:0035967 | 0.00902 | 5.17533 | 1 | 4 | 103 | cellular response to topologically incorrect protein |
| GO:0050670 | 0.00903 | 3.53038 | 2 | 6 | 225 | regulation of lymphocyte proliferation |
| GO:2001236 | 0.00910 | 4.11823 | 1 | 5 | 161 | regulation of extrinsic apoptotic signaling pathway |
| GO:0002696 | 0.00913 | 2.67379 | 4 | 9 | 446 | positive regulation of leukocyte activation |
| GO:0031344 | 0.00921 | 2.21635 | 6 | 13 | 781 | regulation of cell projection organization |
| GO:0010948 | 0.00921 | 3.51418 | 2 | 6 | 226 | negative regulation of cell cycle process |
| GO:0031329 | 0.00929 | 2.29575 | 5 | 12 | 695 | regulation of cellular catabolic process |
| GO:0032612 | 0.00933 | 5.12335 | 1 | 4 | 104 | interleukin-1 production |
| GO:0051983 | 0.00933 | 5.12335 | 1 | 4 | 104 | regulation of chromosome segregation |
| GO:0021795 | 0.00937 | 7.36378 | 0 | 3 | 55 | cerebral cortex cell migration |
| GO:0035019 | 0.00937 | 7.36378 | 0 | 3 | 55 | somatic stem cell population maintenance |
| GO:0046580 | 0.00937 | 7.36378 | 0 | 3 | 55 | negative regulation of Ras protein signal transduction |
| GO:0050701 | 0.00937 | 7.36378 | 0 | 3 | 55 | interleukin-1 secretion |
| GO:0032944 | 0.00940 | 3.49812 | 2 | 6 | 227 | regulation of mononuclear cell proliferation |
| GO:0008306 | 0.00964 | 5.07240 | 1 | 4 | 105 | associative learning |
| GO:0002643 | 0.00968 | 14.95613 | 0 | 2 | 19 | regulation of tolerance induction |
| GO:0002726 | 0.00968 | 14.95613 | 0 | 2 | 19 | positive regulation of T cell cytokine production |
| GO:0035994 | 0.00968 | 14.95613 | 0 | 2 | 19 | response to muscle stretch |
| GO:0042789 | 0.00968 | 14.95613 | 0 | 2 | 19 | mRNA transcription by RNA polymerase II |
| GO:0009914 | 0.00973 | 2.83829 | 3 | 8 | 373 | hormone transport |
| GO:0043254 | 0.00978 | 2.64296 | 4 | 9 | 451 | regulation of protein complex assembly |
| GO:0007062 | 0.00984 | 7.22453 | 0 | 3 | 56 | sister chromatid cohesion |
| GO:0045620 | 0.00984 | 7.22453 | 0 | 3 | 56 | negative regulation of lymphocyte differentiation |
| GO:1905517 | 0.00984 | 7.22453 | 0 | 3 | 56 | macrophage migration |
| GO:0048661 | 0.00996 | 5.02246 | 1 | 4 | 106 | positive regulation of smooth muscle cell proliferation |
| GO:0051017 | 0.01005 | 4.01457 | 1 | 5 | 165 | actin filament bundle assembly |
| GO:0044089 | 0.01007 | 2.48235 | 4 | 10 | 534 | positive regulation of cellular component biogenesis |
| GO:0090596 | 0.01010 | 3.07535 | 2 | 7 | 301 | sensory organ morphogenesis |
| GO:2001234 | 0.01019 | 3.43533 | 2 | 6 | 231 | negative regulation of apoptotic signaling pathway |
| GO:0046883 | 0.01028 | 3.06479 | 2 | 7 | 302 | regulation of hormone secretion |
| GO:0050714 | 0.01028 | 3.06479 | 2 | 7 | 302 | positive regulation of protein secretion |
| GO:0001823 | 0.01028 | 4.97348 | 1 | 4 | 107 | mesonephros development |
| GO:0014896 | 0.01028 | 4.97348 | 1 | 4 | 107 | muscle hypertrophy |
| GO:0048145 | 0.01028 | 4.97348 | 1 | 4 | 107 | regulation of fibroblast proliferation |
| GO:0097756 | 0.01028 | 4.97348 | 1 | 4 | 107 | negative regulation of blood vessel diameter |
| GO:0010463 | 0.01033 | 7.09043 | 0 | 3 | 57 | mesenchymal cell proliferation |
| GO:0042551 | 0.01033 | 7.09043 | 0 | 3 | 57 | neuron maturation |
| GO:0002237 | 0.01033 | 2.80703 | 3 | 8 | 377 | response to molecule of bacterial origin |
| GO:0032872 | 0.01039 | 3.41998 | 2 | 6 | 232 | regulation of stress-activated MAPK cascade |
| GO:0010243 | 0.01044 | 2.11228 | 7 | 14 | 883 | response to organonitrogen compound |
| GO:0048285 | 0.01046 | 2.61282 | 4 | 9 | 456 | organelle fission |
| GO:0051049 | 0.01050 | 1.73845 | 15 | 25 | 1946 | regulation of transport |
| GO:0030316 | 0.01061 | 4.92544 | 1 | 4 | 108 | osteoclast differentiation |
| GO:0050910 | 0.01070 | 14.12462 | 0 | 2 | 20 | detection of mechanical stimulus involved in sensory perception of sound |
| GO:0070633 | 0.01070 | 14.12462 | 0 | 2 | 20 | transepithelial transport |
| GO:1900409 | 0.01070 | 14.12462 | 0 | 2 | 20 | positive regulation of cellular response to oxidative stress |
| GO:2000678 | 0.01070 | 14.12462 | 0 | 2 | 20 | negative regulation of transcription regulatory region DNA binding |
| GO:0030335 | 0.01070 | 2.45834 | 4 | 10 | 539 | positive regulation of cell migration |
| GO:0061572 | 0.01080 | 3.94017 | 1 | 5 | 168 | actin filament bundle organization |
| GO:0070302 | 0.01081 | 3.38968 | 2 | 6 | 234 | regulation of stress-activated protein kinase signaling cascade |
| GO:0048144 | 0.01095 | 4.87832 | 1 | 4 | 109 | fibroblast proliferation |
| GO:0050867 | 0.01117 | 2.58335 | 4 | 9 | 461 | positive regulation of cell activation |
| GO:1901698 | 0.01120 | 2.03686 | 8 | 15 | 982 | response to nitrogen compound |
| GO:0006986 | 0.01130 | 4.83209 | 1 | 4 | 110 | response to unfolded protein |
| GO:0042129 | 0.01132 | 3.89207 | 1 | 5 | 170 | regulation of T cell proliferation |
| GO:0008347 | 0.01134 | 6.83661 | 0 | 3 | 59 | glial cell migration |
| GO:0060711 | 0.01134 | 6.83661 | 0 | 3 | 59 | labyrinthine layer development |
| GO:1903078 | 0.01134 | 6.83661 | 0 | 3 | 59 | positive regulation of protein localization to plasma membrane |
| GO:0007507 | 0.01135 | 2.32285 | 5 | 11 | 628 | heart development |
| GO:0046651 | 0.01136 | 3.00291 | 2 | 7 | 308 | lymphocyte proliferation |
| GO:0006470 | 0.01168 | 3.33065 | 2 | 6 | 238 | protein dephosphorylation |
| GO:0070663 | 0.01168 | 3.33065 | 2 | 6 | 238 | regulation of leukocyte proliferation |
| GO:0032943 | 0.01174 | 2.98282 | 2 | 7 | 310 | mononuclear cell proliferation |
| GO:0032332 | 0.01177 | 13.38063 | 0 | 2 | 21 | positive regulation of chondrocyte differentiation |
| GO:1901654 | 0.01187 | 3.84512 | 1 | 5 | 172 | response to ketone |
| GO:0050982 | 0.01187 | 6.71637 | 0 | 3 | 60 | detection of mechanical stimulus |
| GO:0090257 | 0.01190 | 3.31621 | 2 | 6 | 239 | regulation of muscle system process |
| GO:0010721 | 0.01195 | 2.73176 | 3 | 8 | 387 | negative regulation of cell development |
| GO:0031175 | 0.01198 | 1.97184 | 9 | 16 | 1083 | neuron projection development |
| GO:0022607 | 0.01209 | 1.60622 | 22 | 33 | 2807 | cellular component assembly |
| GO:0007420 | 0.01212 | 2.29986 | 5 | 11 | 634 | brain development |
| GO:0031644 | 0.01214 | 3.82206 | 1 | 5 | 173 | regulation of neurological system process |
| GO:0042698 | 0.01242 | 6.60029 | 0 | 3 | 61 | ovulation cycle |
| GO:0051058 | 0.01242 | 6.60029 | 0 | 3 | 61 | negative regulation of small GTPase mediated signal transduction |
| GO:0043583 | 0.01260 | 3.27363 | 2 | 6 | 242 | ear development |
| GO:0035107 | 0.01271 | 3.77677 | 1 | 5 | 175 | appendage morphogenesis |
| GO:0035108 | 0.01271 | 3.77677 | 1 | 5 | 175 | limb morphogenesis |
| GO:0007063 | 0.01288 | 12.71105 | 0 | 2 | 22 | regulation of sister chromatid cohesion |
| GO:0051043 | 0.01288 | 12.71105 | 0 | 2 | 22 | regulation of membrane protein ectodomain proteolysis |
| GO:0051602 | 0.01288 | 12.71105 | 0 | 2 | 22 | response to electrical stimulus |
| GO:0072111 | 0.01288 | 12.71105 | 0 | 2 | 22 | cell proliferation involved in kidney development |
| GO:1904469 | 0.01288 | 12.71105 | 0 | 2 | 22 | positive regulation of tumor necrosis factor secretion |
| GO:0048592 | 0.01300 | 3.75452 | 1 | 5 | 176 | eye morphogenesis |
| GO:0071375 | 0.01307 | 3.24583 | 2 | 6 | 244 | cellular response to peptide hormone stimulus |
| GO:0007059 | 0.01314 | 2.91457 | 2 | 7 | 317 | chromosome segregation |
| GO:0044770 | 0.01319 | 2.68139 | 3 | 8 | 394 | cell cycle phase transition |
| GO:0018105 | 0.01335 | 2.90507 | 3 | 7 | 318 | peptidyl-serine phosphorylation |
| GO:0030098 | 0.01338 | 2.67434 | 3 | 8 | 395 | lymphocyte differentiation |
| GO:0040007 | 0.01340 | 1.94506 | 9 | 16 | 1097 | growth |
| GO:0002040 | 0.01351 | 4.57203 | 1 | 4 | 116 | sprouting angiogenesis |
| GO:0009894 | 0.01352 | 2.10285 | 6 | 13 | 821 | regulation of catabolic process |
| GO:0032677 | 0.01354 | 6.37972 | 0 | 3 | 63 | regulation of interleukin-8 production |
| GO:0032722 | 0.01354 | 6.37972 | 0 | 3 | 63 | positive regulation of chemokine production |
| GO:0043524 | 0.01360 | 3.71079 | 1 | 5 | 178 | negative regulation of neuron apoptotic process |
| GO:0002064 | 0.01381 | 3.20501 | 2 | 6 | 247 | epithelial cell development |
| GO:2000147 | 0.01384 | 2.35788 | 4 | 10 | 561 | positive regulation of cell motility |
| GO:0140013 | 0.01390 | 3.68930 | 1 | 5 | 179 | meiotic nuclear division |
| GO:0002827 | 0.01403 | 12.10524 | 0 | 2 | 23 | positive regulation of T-helper 1 type immune response |
| GO:0032461 | 0.01403 | 12.10524 | 0 | 2 | 23 | positive regulation of protein oligomerization |
| GO:0043371 | 0.01403 | 12.10524 | 0 | 2 | 23 | negative regulation of CD4-positive, alpha-beta T cell differentiation |
| GO:1902884 | 0.01403 | 12.10524 | 0 | 2 | 23 | positive regulation of response to oxidative stress |
| GO:2000316 | 0.01403 | 12.10524 | 0 | 2 | 23 | regulation of T-helper 17 type immune response |
| GO:2000831 | 0.01403 | 12.10524 | 0 | 2 | 23 | regulation of steroid hormone secretion |
| GO:0002763 | 0.01413 | 6.27486 | 1 | 3 | 64 | positive regulation of myeloid leukocyte differentiation |
| GO:0000819 | 0.01421 | 3.66806 | 1 | 5 | 180 | sister chromatid segregation |
| GO:0060349 | 0.01431 | 4.49142 | 1 | 4 | 118 | bone morphogenesis |
| GO:0042063 | 0.01443 | 2.85848 | 3 | 7 | 323 | gliogenesis |
| GO:0071407 | 0.01457 | 2.46636 | 4 | 9 | 482 | cellular response to organic cyclic compound |
| GO:0050868 | 0.01472 | 4.45217 | 1 | 4 | 119 | negative regulation of T cell activation |
| GO:0030032 | 0.01473 | 6.17339 | 1 | 3 | 65 | lamellipodium assembly |
| GO:0060389 | 0.01473 | 6.17339 | 1 | 3 | 65 | pathway-restricted SMAD protein phosphorylation |
| GO:0150076 | 0.01473 | 6.17339 | 1 | 3 | 65 | neuroinflammatory response |
| GO:0060541 | 0.01484 | 3.15213 | 2 | 6 | 251 | respiratory system development |
| GO:0071417 | 0.01497 | 2.32757 | 4 | 10 | 568 | cellular response to organonitrogen compound |
| GO:0010508 | 0.01513 | 4.41360 | 1 | 4 | 120 | positive regulation of autophagy |
| GO:0006882 | 0.01523 | 11.55450 | 0 | 2 | 24 | cellular zinc ion homeostasis |
| GO:0042044 | 0.01523 | 11.55450 | 0 | 2 | 24 | fluid transport |
| GO:1904377 | 0.01534 | 6.07513 | 1 | 3 | 66 | positive regulation of protein localization to cell periphery |
| GO:0008286 | 0.01556 | 4.37569 | 1 | 4 | 121 | insulin receptor signaling pathway |
| GO:0046546 | 0.01556 | 4.37569 | 1 | 4 | 121 | development of primary male sexual characteristics |
| GO:0048565 | 0.01556 | 4.37569 | 1 | 4 | 121 | digestive tract development |
| GO:0120031 | 0.01566 | 2.43481 | 4 | 9 | 488 | plasma membrane bounded cell projection assembly |
| GO:0001982 | 0.01571 | 126.51648 | 0 | 1 | 2 | baroreceptor response to decreased systemic arterial blood pressure |
| GO:0002537 | 0.01571 | 126.51648 | 0 | 1 | 2 | nitric oxide production involved in inflammatory response |
| GO:0002649 | 0.01571 | 126.51648 | 0 | 1 | 2 | regulation of tolerance induction to self antigen |
| GO:0002661 | 0.01571 | 126.51648 | 0 | 1 | 2 | regulation of B cell tolerance induction |
| GO:0002663 | 0.01571 | 126.51648 | 0 | 1 | 2 | positive regulation of B cell tolerance induction |
| GO:0003430 | 0.01571 | 126.51648 | 0 | 1 | 2 | growth plate cartilage chondrocyte growth |
| GO:0006429 | 0.01571 | 126.51648 | 0 | 1 | 2 | leucyl-tRNA aminoacylation |
| GO:0015688 | 0.01571 | 126.51648 | 0 | 1 | 2 | iron chelate transport |
| GO:0015891 | 0.01571 | 126.51648 | 0 | 1 | 2 | siderophore transport |
| GO:0022400 | 0.01571 | 126.51648 | 0 | 1 | 2 | regulation of rhodopsin mediated signaling pathway |
| GO:0031022 | 0.01571 | 126.51648 | 0 | 1 | 2 | nuclear migration along microfilament |
| GO:0032707 | 0.01571 | 126.51648 | 0 | 1 | 2 | negative regulation of interleukin-23 production |
| GO:0035377 | 0.01571 | 126.51648 | 0 | 1 | 2 | transepithelial water transport |
| GO:0038195 | 0.01571 | 126.51648 | 0 | 1 | 2 | urokinase plasminogen activator signaling pathway |
| GO:0044332 | 0.01571 | 126.51648 | 0 | 1 | 2 | Wnt signaling pathway involved in dorsal/ventral axis specification |
| GO:0045366 | 0.01571 | 126.51648 | 0 | 1 | 2 | regulation of interleukin-13 biosynthetic process |
| GO:0045368 | 0.01571 | 126.51648 | 0 | 1 | 2 | positive regulation of interleukin-13 biosynthetic process |
| GO:0045818 | 0.01571 | 126.51648 | 0 | 1 | 2 | negative regulation of glycogen catabolic process |
| GO:0045819 | 0.01571 | 126.51648 | 0 | 1 | 2 | positive regulation of glycogen catabolic process |
| GO:0048632 | 0.01571 | 126.51648 | 0 | 1 | 2 | negative regulation of skeletal muscle tissue growth |
| GO:0048749 | 0.01571 | 126.51648 | 0 | 1 | 2 | compound eye development |
| GO:0060364 | 0.01571 | 126.51648 | 0 | 1 | 2 | frontal suture morphogenesis |
| GO:0060434 | 0.01571 | 126.51648 | 0 | 1 | 2 | bronchus morphogenesis |
| GO:0060715 | 0.01571 | 126.51648 | 0 | 1 | 2 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development |
| GO:0060734 | 0.01571 | 126.51648 | 0 | 1 | 2 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation |
| GO:0060764 | 0.01571 | 126.51648 | 0 | 1 | 2 | cell-cell signaling involved in mammary gland development |
| GO:0070426 | 0.01571 | 126.51648 | 0 | 1 | 2 | positive regulation of nucleotide-binding oligomerization domain containing signaling pathway |
| GO:0070434 | 0.01571 | 126.51648 | 0 | 1 | 2 | positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
| GO:0071336 | 0.01571 | 126.51648 | 0 | 1 | 2 | regulation of hair follicle cell proliferation |
| GO:0071505 | 0.01571 | 126.51648 | 0 | 1 | 2 | response to mycophenolic acid |
| GO:0071506 | 0.01571 | 126.51648 | 0 | 1 | 2 | cellular response to mycophenolic acid |
| GO:0071550 | 0.01571 | 126.51648 | 0 | 1 | 2 | death-inducing signaling complex assembly |
| GO:0072301 | 0.01571 | 126.51648 | 0 | 1 | 2 | regulation of metanephric glomerular mesangial cell proliferation |
| GO:0086100 | 0.01571 | 126.51648 | 0 | 1 | 2 | endothelin receptor signaling pathway |
| GO:0098758 | 0.01571 | 126.51648 | 0 | 1 | 2 | response to interleukin-8 |
| GO:0098759 | 0.01571 | 126.51648 | 0 | 1 | 2 | cellular response to interleukin-8 |
| GO:0120077 | 0.01571 | 126.51648 | 0 | 1 | 2 | angiogenic sprout fusion |
| GO:0120078 | 0.01571 | 126.51648 | 0 | 1 | 2 | cell adhesion involved in sprouting angiogenesis |
| GO:1900673 | 0.01571 | 126.51648 | 0 | 1 | 2 | olefin metabolic process |
| GO:1902159 | 0.01571 | 126.51648 | 0 | 1 | 2 | regulation of cyclic nucleotide-gated ion channel activity |
| GO:1902310 | 0.01571 | 126.51648 | 0 | 1 | 2 | positive regulation of peptidyl-serine dephosphorylation |
| GO:1902941 | 0.01571 | 126.51648 | 0 | 1 | 2 | regulation of voltage-gated chloride channel activity |
| GO:1902943 | 0.01571 | 126.51648 | 0 | 1 | 2 | positive regulation of voltage-gated chloride channel activity |
| GO:1904092 | 0.01571 | 126.51648 | 0 | 1 | 2 | regulation of autophagic cell death |
| GO:1904093 | 0.01571 | 126.51648 | 0 | 1 | 2 | negative regulation of autophagic cell death |
| GO:1904446 | 0.01571 | 126.51648 | 0 | 1 | 2 | positive regulation of establishment of Sertoli cell barrier |
| GO:1990428 | 0.01571 | 126.51648 | 0 | 1 | 2 | miRNA transport |
| GO:2000053 | 0.01571 | 126.51648 | 0 | 1 | 2 | regulation of Wnt signaling pathway involved in dorsal/ventral axis specification |
| GO:2000054 | 0.01571 | 126.51648 | 0 | 1 | 2 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification |
| GO:2000393 | 0.01571 | 126.51648 | 0 | 1 | 2 | negative regulation of lamellipodium morphogenesis |
| GO:2000521 | 0.01571 | 126.51648 | 0 | 1 | 2 | negative regulation of immunological synapse formation |
| GO:2000740 | 0.01571 | 126.51648 | 0 | 1 | 2 | negative regulation of mesenchymal stem cell differentiation |
| GO:2000872 | 0.01571 | 126.51648 | 0 | 1 | 2 | positive regulation of progesterone secretion |
| GO:2001189 | 0.01571 | 126.51648 | 0 | 1 | 2 | negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
| GO:0034330 | 0.01592 | 3.10095 | 2 | 6 | 255 | cell junction organization |
| GO:0043491 | 0.01616 | 3.54553 | 1 | 5 | 186 | protein kinase B signaling |
| GO:0000280 | 0.01617 | 2.57938 | 3 | 8 | 409 | nuclear division |
| GO:0046649 | 0.01619 | 2.05021 | 7 | 13 | 841 | lymphocyte activation |
| GO:0002793 | 0.01629 | 2.78691 | 3 | 7 | 331 | positive regulation of peptide secretion |
| GO:0070661 | 0.01629 | 2.78691 | 3 | 7 | 331 | leukocyte proliferation |
| GO:0000289 | 0.01647 | 11.05165 | 0 | 2 | 25 | nuclear-transcribed mRNA poly(A) tail shortening |
| GO:0021801 | 0.01647 | 11.05165 | 0 | 2 | 25 | cerebral cortex radial glia guided migration |
| GO:0022030 | 0.01647 | 11.05165 | 0 | 2 | 25 | telencephalon glial cell migration |
| GO:0030903 | 0.01647 | 11.05165 | 0 | 2 | 25 | notochord development |
| GO:0045737 | 0.01647 | 11.05165 | 0 | 2 | 25 | positive regulation of cyclin-dependent protein serine/threonine kinase activity |
| GO:0046426 | 0.01647 | 11.05165 | 0 | 2 | 25 | negative regulation of JAK-STAT cascade |
| GO:0046688 | 0.01647 | 11.05165 | 0 | 2 | 25 | response to copper ion |
| GO:0055069 | 0.01647 | 11.05165 | 0 | 2 | 25 | zinc ion homeostasis |
| GO:1905939 | 0.01647 | 11.05165 | 0 | 2 | 25 | regulation of gonad development |
| GO:0051403 | 0.01649 | 3.07597 | 2 | 6 | 257 | stress-activated MAPK cascade |
| GO:0046328 | 0.01684 | 3.50648 | 1 | 5 | 188 | regulation of JNK cascade |
| GO:0033138 | 0.01687 | 4.26574 | 1 | 4 | 124 | positive regulation of peptidyl-serine phosphorylation |
| GO:0051129 | 0.01688 | 2.10470 | 6 | 12 | 755 | negative regulation of cellular component organization |
| GO:0002699 | 0.01706 | 3.05138 | 2 | 6 | 259 | positive regulation of immune effector process |
| GO:0051272 | 0.01706 | 2.27736 | 5 | 10 | 580 | positive regulation of cellular component movement |
| GO:0032637 | 0.01727 | 5.79823 | 1 | 3 | 69 | interleukin-8 production |
| GO:0045576 | 0.01727 | 5.79823 | 1 | 3 | 69 | mast cell activation |
| GO:0048146 | 0.01727 | 5.79823 | 1 | 3 | 69 | positive regulation of fibroblast proliferation |
| GO:0055117 | 0.01727 | 5.79823 | 1 | 3 | 69 | regulation of cardiac muscle contraction |
| GO:0010212 | 0.01732 | 4.23030 | 1 | 4 | 125 | response to ionizing radiation |
| GO:0045665 | 0.01735 | 3.03924 | 2 | 6 | 260 | negative regulation of neuron differentiation |
| GO:0009299 | 0.01775 | 10.59070 | 0 | 2 | 26 | mRNA transcription |
| GO:0035929 | 0.01775 | 10.59070 | 0 | 2 | 26 | steroid hormone secretion |
| GO:0045742 | 0.01775 | 10.59070 | 0 | 2 | 26 | positive regulation of epidermal growth factor receptor signaling pathway |
| GO:0060716 | 0.01775 | 10.59070 | 0 | 2 | 26 | labyrinthine layer blood vessel development |
| GO:0071549 | 0.01775 | 10.59070 | 0 | 2 | 26 | cellular response to dexamethasone stimulus |
| GO:0072012 | 0.01775 | 10.59070 | 0 | 2 | 26 | glomerulus vasculature development |
| GO:1904893 | 0.01775 | 10.59070 | 0 | 2 | 26 | negative regulation of STAT cascade |
| GO:0009582 | 0.01779 | 4.19544 | 1 | 4 | 126 | detection of abiotic stimulus |
| GO:0021915 | 0.01791 | 3.44947 | 2 | 5 | 191 | neural tube development |
| GO:0022029 | 0.01794 | 5.71144 | 1 | 3 | 70 | telencephalon cell migration |
| GO:0048705 | 0.01795 | 3.01523 | 2 | 6 | 262 | skeletal system morphogenesis |
| GO:0030031 | 0.01825 | 2.36911 | 4 | 9 | 501 | cell projection assembly |
| GO:0009581 | 0.01825 | 4.16115 | 1 | 4 | 127 | detection of external stimulus |
| GO:0048640 | 0.01825 | 4.16115 | 1 | 4 | 127 | negative regulation of developmental growth |
| GO:0031589 | 0.01831 | 2.71880 | 3 | 7 | 339 | cell-substrate adhesion |
| GO:0002711 | 0.01863 | 5.62721 | 1 | 3 | 71 | positive regulation of T cell mediated immunity |
| GO:0042509 | 0.01863 | 5.62721 | 1 | 3 | 71 | regulation of tyrosine phosphorylation of STAT protein |
| GO:0048609 | 0.01876 | 2.00742 | 7 | 13 | 858 | multicellular organismal reproductive process |
| GO:0042593 | 0.01887 | 2.97991 | 2 | 6 | 265 | glucose homeostasis |
| GO:0008340 | 0.01907 | 10.16663 | 0 | 2 | 27 | determination of adult lifespan |
| GO:0036003 | 0.01907 | 10.16663 | 0 | 2 | 27 | positive regulation of transcription from RNA polymerase II promoter in response to stress |
| GO:0060713 | 0.01907 | 10.16663 | 0 | 2 | 27 | labyrinthine layer morphogenesis |
| GO:0061437 | 0.01907 | 10.16663 | 0 | 2 | 27 | renal system vasculature development |
| GO:0061440 | 0.01907 | 10.16663 | 0 | 2 | 27 | kidney vasculature development |
| GO:0050878 | 0.01911 | 2.69410 | 3 | 7 | 342 | regulation of body fluid levels |
| GO:0033500 | 0.01918 | 2.96832 | 2 | 6 | 266 | carbohydrate homeostasis |
| GO:0051101 | 0.01921 | 4.09421 | 1 | 4 | 129 | regulation of DNA binding |
| GO:0033043 | 0.01925 | 1.82264 | 10 | 17 | 1242 | regulation of organelle organization |
| GO:0048645 | 0.01933 | 5.54541 | 1 | 3 | 72 | animal organ formation |
| GO:0002706 | 0.01940 | 3.37626 | 2 | 5 | 195 | regulation of lymphocyte mediated immunity |
| GO:0050731 | 0.01940 | 3.37626 | 2 | 5 | 195 | positive regulation of peptidyl-tyrosine phosphorylation |
| GO:0006996 | 0.01954 | 1.49638 | 28 | 39 | 3568 | organelle organization |
| GO:0040017 | 0.01957 | 2.22528 | 5 | 10 | 593 | positive regulation of locomotion |
| GO:0007093 | 0.01971 | 4.06154 | 1 | 4 | 130 | mitotic cell cycle checkpoint |
| GO:0120035 | 0.01971 | 2.05605 | 6 | 12 | 772 | regulation of plasma membrane bounded cell projection organization |
| GO:0034599 | 0.01982 | 2.94540 | 2 | 6 | 268 | cellular response to oxidative stress |
| GO:0050673 | 0.01985 | 2.47866 | 3 | 8 | 425 | epithelial cell proliferation |
| GO:0021885 | 0.02004 | 5.46595 | 1 | 3 | 73 | forebrain cell migration |
| GO:1903038 | 0.02020 | 4.02938 | 1 | 4 | 131 | negative regulation of leukocyte cell-cell adhesion |
| GO:0019932 | 0.02035 | 2.46661 | 3 | 8 | 427 | second-messenger-mediated signaling |
| GO:0001945 | 0.02043 | 9.77518 | 0 | 2 | 28 | lymph vessel development |
| GO:0002507 | 0.02043 | 9.77518 | 0 | 2 | 28 | tolerance induction |
| GO:0043032 | 0.02043 | 9.77518 | 0 | 2 | 28 | positive regulation of macrophage activation |
| GO:0060444 | 0.02043 | 9.77518 | 0 | 2 | 28 | branching involved in mammary gland duct morphogenesis |
| GO:0090200 | 0.02043 | 9.77518 | 0 | 2 | 28 | positive regulation of release of cytochrome c from mitochondria |
| GO:1901186 | 0.02043 | 9.77518 | 0 | 2 | 28 | positive regulation of ERBB signaling pathway |
| GO:1904031 | 0.02043 | 9.77518 | 0 | 2 | 28 | positive regulation of cyclin-dependent protein kinase activity |
| GO:0043542 | 0.02057 | 3.32334 | 2 | 5 | 198 | endothelial cell migration |
| GO:1903046 | 0.02057 | 3.32334 | 2 | 5 | 198 | meiotic cell cycle process |
| GO:0032504 | 0.02058 | 1.98064 | 7 | 13 | 869 | multicellular organism reproduction |
| GO:0030177 | 0.02071 | 3.99773 | 1 | 4 | 132 | positive regulation of Wnt signaling pathway |
| GO:0010822 | 0.02077 | 5.38873 | 1 | 3 | 74 | positive regulation of mitochondrion organization |
| GO:0014743 | 0.02077 | 5.38873 | 1 | 3 | 74 | regulation of muscle hypertrophy |
| GO:1901224 | 0.02077 | 5.38873 | 1 | 3 | 74 | positive regulation of NIK/NF-kappaB signaling |
| GO:0090287 | 0.02080 | 2.91167 | 2 | 6 | 271 | regulation of cellular response to growth factor stimulus |
| GO:0060485 | 0.02114 | 2.90060 | 2 | 6 | 272 | mesenchyme development |
| GO:0009855 | 0.02123 | 3.96657 | 1 | 4 | 133 | determination of bilateral symmetry |
| GO:0035966 | 0.02123 | 3.96657 | 1 | 4 | 133 | response to topologically incorrect protein |
| GO:0050906 | 0.02123 | 3.96657 | 1 | 4 | 133 | detection of stimulus involved in sensory perception |
| GO:0007260 | 0.02151 | 5.31366 | 1 | 3 | 75 | tyrosine phosphorylation of STAT protein |
| GO:0008625 | 0.02151 | 5.31366 | 1 | 3 | 75 | extrinsic apoptotic signaling pathway via death domain receptors |
| GO:0009799 | 0.02175 | 3.93588 | 1 | 4 | 134 | specification of symmetry |
| GO:0043281 | 0.02178 | 3.27204 | 2 | 5 | 201 | regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0003413 | 0.02183 | 9.41273 | 0 | 2 | 29 | chondrocyte differentiation involved in endochondral bone morphogenesis |
| GO:0030318 | 0.02183 | 9.41273 | 0 | 2 | 29 | melanocyte differentiation |
| GO:0033137 | 0.02183 | 9.41273 | 0 | 2 | 29 | negative regulation of peptidyl-serine phosphorylation |
| GO:0071354 | 0.02183 | 9.41273 | 0 | 2 | 29 | cellular response to interleukin-6 |
| GO:1900027 | 0.02183 | 9.41273 | 0 | 2 | 29 | regulation of ruffle assembly |
| GO:0007254 | 0.02220 | 3.25529 | 2 | 5 | 202 | JNK cascade |
| GO:0019229 | 0.02227 | 5.24064 | 1 | 3 | 76 | regulation of vasoconstriction |
| GO:0051222 | 0.02244 | 2.41954 | 3 | 8 | 435 | positive regulation of protein transport |
| GO:0003008 | 0.02245 | 1.52327 | 23 | 33 | 2939 | system process |
| GO:0050727 | 0.02257 | 2.59955 | 3 | 7 | 354 | regulation of inflammatory response |
| GO:0009791 | 0.02282 | 3.87591 | 1 | 4 | 136 | post-embryonic development |
| GO:0030148 | 0.02304 | 5.16959 | 1 | 3 | 77 | sphingolipid biosynthetic process |
| GO:0061180 | 0.02304 | 5.16959 | 1 | 3 | 77 | mammary gland epithelium development |
| GO:0001666 | 0.02304 | 3.22229 | 2 | 5 | 204 | response to hypoxia |
| GO:0030072 | 0.02322 | 2.83587 | 2 | 6 | 278 | peptide hormone secretion |
| GO:0002825 | 0.02327 | 9.07616 | 0 | 2 | 30 | regulation of T-helper 1 type immune response |
| GO:0010043 | 0.02327 | 9.07616 | 0 | 2 | 30 | response to zinc ion |
| GO:0048384 | 0.02327 | 9.07616 | 0 | 2 | 30 | retinoic acid receptor signaling pathway |
| GO:0022604 | 0.02332 | 2.26550 | 4 | 9 | 523 | regulation of cell morphogenesis |
| GO:0000733 | 0.02347 | 63.25549 | 0 | 1 | 3 | DNA strand renaturation |
| GO:0002514 | 0.02347 | 63.25549 | 0 | 1 | 3 | B cell tolerance induction |
| GO:0014064 | 0.02347 | 63.25549 | 0 | 1 | 3 | positive regulation of serotonin secretion |
| GO:0014878 | 0.02347 | 63.25549 | 0 | 1 | 3 | response to electrical stimulus involved in regulation of muscle adaptation |
| GO:0021775 | 0.02347 | 63.25549 | 0 | 1 | 3 | smoothened signaling pathway involved in ventral spinal cord interneuron specification |
| GO:0021776 | 0.02347 | 63.25549 | 0 | 1 | 3 | smoothened signaling pathway involved in spinal cord motor neuron cell fate specification |
| GO:0021817 | 0.02347 | 63.25549 | 0 | 1 | 3 | nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration |
| GO:0032423 | 0.02347 | 63.25549 | 0 | 1 | 3 | regulation of mismatch repair |
| GO:0034263 | 0.02347 | 63.25549 | 0 | 1 | 3 | positive regulation of autophagy in response to ER overload |
| GO:0035880 | 0.02347 | 63.25549 | 0 | 1 | 3 | embryonic nail plate morphogenesis |
| GO:0042231 | 0.02347 | 63.25549 | 0 | 1 | 3 | interleukin-13 biosynthetic process |
| GO:0043578 | 0.02347 | 63.25549 | 0 | 1 | 3 | nuclear matrix organization |
| GO:0046208 | 0.02347 | 63.25549 | 0 | 1 | 3 | spermine catabolic process |
| GO:0048320 | 0.02347 | 63.25549 | 0 | 1 | 3 | axial mesoderm formation |
| GO:0048499 | 0.02347 | 63.25549 | 0 | 1 | 3 | synaptic vesicle membrane organization |
| GO:0060060 | 0.02347 | 63.25549 | 0 | 1 | 3 | post-embryonic retina morphogenesis in camera-type eye |
| GO:0060086 | 0.02347 | 63.25549 | 0 | 1 | 3 | circadian temperature homeostasis |
| GO:0060720 | 0.02347 | 63.25549 | 0 | 1 | 3 | spongiotrophoblast cell proliferation |
| GO:0060722 | 0.02347 | 63.25549 | 0 | 1 | 3 | cell proliferation involved in embryonic placenta development |
| GO:0061357 | 0.02347 | 63.25549 | 0 | 1 | 3 | positive regulation of Wnt protein secretion |
| GO:0070428 | 0.02347 | 63.25549 | 0 | 1 | 3 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway |
| GO:0071335 | 0.02347 | 63.25549 | 0 | 1 | 3 | hair follicle cell proliferation |
| GO:0071898 | 0.02347 | 63.25549 | 0 | 1 | 3 | regulation of estrogen receptor binding |
| GO:0071899 | 0.02347 | 63.25549 | 0 | 1 | 3 | negative regulation of estrogen receptor binding |
| GO:0090292 | 0.02347 | 63.25549 | 0 | 1 | 3 | nuclear matrix anchoring at nuclear membrane |
| GO:0097176 | 0.02347 | 63.25549 | 0 | 1 | 3 | epoxide metabolic process |
| GO:0097724 | 0.02347 | 63.25549 | 0 | 1 | 3 | sperm flagellum movement |
| GO:1902722 | 0.02347 | 63.25549 | 0 | 1 | 3 | positive regulation of prolactin secretion |
| GO:1903971 | 0.02347 | 63.25549 | 0 | 1 | 3 | positive regulation of response to macrophage colony-stimulating factor |
| GO:1903974 | 0.02347 | 63.25549 | 0 | 1 | 3 | positive regulation of cellular response to macrophage colony-stimulating factor stimulus |
| GO:1903984 | 0.02347 | 63.25549 | 0 | 1 | 3 | positive regulation of TRAIL-activated apoptotic signaling pathway |
| GO:1904444 | 0.02347 | 63.25549 | 0 | 1 | 3 | regulation of establishment of Sertoli cell barrier |
| GO:1904761 | 0.02347 | 63.25549 | 0 | 1 | 3 | negative regulation of myofibroblast differentiation |
| GO:1905078 | 0.02347 | 63.25549 | 0 | 1 | 3 | positive regulation of interleukin-17 secretion |
| GO:1905419 | 0.02347 | 63.25549 | 0 | 1 | 3 | sperm flagellum movement involved in flagellated sperm motility |
| GO:1990442 | 0.02347 | 63.25549 | 0 | 1 | 3 | intrinsic apoptotic signaling pathway in response to nitrosative stress |
| GO:2000016 | 0.02347 | 63.25549 | 0 | 1 | 3 | negative regulation of determination of dorsal identity |
| GO:2000182 | 0.02347 | 63.25549 | 0 | 1 | 3 | regulation of progesterone biosynthetic process |
| GO:2000299 | 0.02347 | 63.25549 | 0 | 1 | 3 | negative regulation of Rho-dependent protein serine/threonine kinase activity |
| GO:2000705 | 0.02347 | 63.25549 | 0 | 1 | 3 | regulation of dense core granule biogenesis |
| GO:2000870 | 0.02347 | 63.25549 | 0 | 1 | 3 | regulation of progesterone secretion |
| GO:2001188 | 0.02347 | 63.25549 | 0 | 1 | 3 | regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell |
| GO:0042098 | 0.02347 | 3.20604 | 2 | 5 | 205 | T cell proliferation |
| GO:0043507 | 0.02383 | 5.10044 | 1 | 3 | 78 | positive regulation of JUN kinase activity |
| GO:0045471 | 0.02383 | 5.10044 | 1 | 3 | 78 | response to ethanol |
| GO:0032496 | 0.02413 | 2.56206 | 3 | 7 | 359 | response to lipopolysaccharide |
| GO:0051050 | 0.02440 | 1.83940 | 9 | 15 | 1081 | positive regulation of transport |
| GO:0042060 | 0.02445 | 2.55469 | 3 | 7 | 360 | wound healing |
| GO:0003208 | 0.02463 | 5.03311 | 1 | 3 | 79 | cardiac ventricle morphogenesis |
| GO:0010614 | 0.02475 | 8.76281 | 0 | 2 | 31 | negative regulation of cardiac muscle hypertrophy |
| GO:0043276 | 0.02475 | 8.76281 | 0 | 2 | 31 | anoikis |
| GO:0045662 | 0.02475 | 8.76281 | 0 | 2 | 31 | negative regulation of myoblast differentiation |
| GO:0061036 | 0.02475 | 8.76281 | 0 | 2 | 31 | positive regulation of cartilage development |
| GO:0070741 | 0.02475 | 8.76281 | 0 | 2 | 31 | response to interleukin-6 |
| GO:2000515 | 0.02475 | 8.76281 | 0 | 2 | 31 | negative regulation of CD4-positive, alpha-beta T cell activation |
| GO:0002824 | 0.02505 | 3.76126 | 1 | 4 | 140 | positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains |
| GO:0097305 | 0.02525 | 3.14263 | 2 | 5 | 209 | response to alcohol |
| GO:0043154 | 0.02544 | 4.96753 | 1 | 3 | 80 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process |
| GO:0055088 | 0.02563 | 3.73364 | 1 | 4 | 141 | lipid homeostasis |
| GO:0061041 | 0.02563 | 3.73364 | 1 | 4 | 141 | regulation of wound healing |
| GO:0071496 | 0.02583 | 2.76387 | 2 | 6 | 285 | cellular response to external stimulus |
| GO:0106106 | 0.02621 | 3.70642 | 1 | 4 | 142 | cold-induced thermogenesis |
| GO:0120161 | 0.02621 | 3.70642 | 1 | 4 | 142 | regulation of cold-induced thermogenesis |
| GO:0010591 | 0.02626 | 8.47035 | 0 | 2 | 32 | regulation of lamellipodium assembly |
| GO:0036475 | 0.02626 | 8.47035 | 0 | 2 | 32 | neuron death in response to oxidative stress |
| GO:0045616 | 0.02626 | 8.47035 | 0 | 2 | 32 | regulation of keratinocyte differentiation |
| GO:0051642 | 0.02626 | 8.47035 | 0 | 2 | 32 | centrosome localization |
| GO:0060669 | 0.02626 | 8.47035 | 0 | 2 | 32 | embryonic placenta morphogenesis |
| GO:0060706 | 0.02626 | 8.47035 | 0 | 2 | 32 | cell differentiation involved in embryonic placenta development |
| GO:0072538 | 0.02626 | 8.47035 | 0 | 2 | 32 | T-helper 17 type immune response |
| GO:1903203 | 0.02626 | 8.47035 | 0 | 2 | 32 | regulation of oxidative stress-induced neuron death |
| GO:0031646 | 0.02627 | 4.90363 | 1 | 3 | 81 | positive regulation of neurological system process |
| GO:0043367 | 0.02627 | 4.90363 | 1 | 3 | 81 | CD4-positive, alpha-beta T cell differentiation |
| GO:0016311 | 0.02643 | 2.51133 | 3 | 7 | 366 | dephosphorylation |
| GO:0007224 | 0.02680 | 3.67959 | 1 | 4 | 143 | smoothened signaling pathway |
| GO:0019233 | 0.02680 | 3.67959 | 1 | 4 | 143 | sensory perception of pain |
| GO:0046330 | 0.02680 | 3.67959 | 1 | 4 | 143 | positive regulation of JNK cascade |
| GO:1901991 | 0.02680 | 3.67959 | 1 | 4 | 143 | negative regulation of mitotic cell cycle phase transition |
| GO:0050707 | 0.02710 | 3.08165 | 2 | 5 | 213 | regulation of cytokine secretion |
| GO:0050801 | 0.02776 | 1.94974 | 6 | 12 | 812 | ion homeostasis |
| GO:0009416 | 0.02780 | 2.71461 | 2 | 6 | 290 | response to light stimulus |
| GO:0071219 | 0.02780 | 2.71461 | 2 | 6 | 290 | cellular response to molecule of bacterial origin |
| GO:0032660 | 0.02782 | 8.19676 | 0 | 2 | 33 | regulation of interleukin-17 production |
| GO:0061842 | 0.02782 | 8.19676 | 0 | 2 | 33 | microtubule organizing center localization |
| GO:0009617 | 0.02790 | 1.89320 | 7 | 13 | 907 | response to bacterium |
| GO:0006942 | 0.02797 | 4.78062 | 1 | 3 | 83 | regulation of striated muscle contraction |
| GO:0071674 | 0.02797 | 4.78062 | 1 | 3 | 83 | mononuclear cell migration |
| GO:1904951 | 0.02799 | 2.31452 | 4 | 8 | 454 | positive regulation of establishment of protein localization |
| GO:0002274 | 0.02807 | 3.05203 | 2 | 5 | 215 | myeloid leukocyte activation |
| GO:0045637 | 0.02807 | 3.05203 | 2 | 5 | 215 | regulation of myeloid cell differentiation |
| GO:1901699 | 0.02844 | 2.08558 | 5 | 10 | 631 | cellular response to nitrogen compound |
| GO:0071214 | 0.02862 | 2.69539 | 2 | 6 | 292 | cellular response to abiotic stimulus |
| GO:0097193 | 0.02862 | 2.69539 | 2 | 6 | 292 | intrinsic apoptotic signaling pathway |
| GO:0104004 | 0.02862 | 2.69539 | 2 | 6 | 292 | cellular response to environmental stimulus |
| GO:0007010 | 0.02922 | 1.72848 | 10 | 17 | 1305 | cytoskeleton organization |
| GO:0002821 | 0.02926 | 3.57604 | 1 | 4 | 147 | positive regulation of adaptive immune response |
| GO:0000186 | 0.02940 | 7.94026 | 0 | 2 | 34 | activation of MAPKK activity |
| GO:0002931 | 0.02940 | 7.94026 | 0 | 2 | 34 | response to ischemia |
| GO:0045137 | 0.02955 | 3.00865 | 2 | 5 | 218 | development of primary sexual characteristics |
| GO:0042632 | 0.02973 | 4.66362 | 1 | 3 | 85 | cholesterol homeostasis |
| GO:0045666 | 0.03025 | 2.27804 | 4 | 8 | 461 | positive regulation of neuron differentiation |
| GO:0003281 | 0.03063 | 4.60723 | 1 | 3 | 86 | ventricular septum development |
| GO:0055092 | 0.03063 | 4.60723 | 1 | 3 | 86 | sterol homeostasis |
| GO:0038084 | 0.03103 | 7.69931 | 0 | 2 | 35 | vascular endothelial growth factor signaling pathway |
| GO:0000320 | 0.03117 | 42.16850 | 0 | 1 | 4 | re-entry into mitotic cell cycle |
| GO:0001994 | 0.03117 | 42.16850 | 0 | 1 | 4 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure |
| GO:0001996 | 0.03117 | 42.16850 | 0 | 1 | 4 | positive regulation of heart rate by epinephrine-norepinephrine |
| GO:0001997 | 0.03117 | 42.16850 | 0 | 1 | 4 | positive regulation of the force of heart contraction by epinephrine-norepinephrine |
| GO:0002538 | 0.03117 | 42.16850 | 0 | 1 | 4 | arachidonic acid metabolite production involved in inflammatory response |
| GO:0003099 | 0.03117 | 42.16850 | 0 | 1 | 4 | positive regulation of the force of heart contraction by chemical signal |
| GO:0003274 | 0.03117 | 42.16850 | 0 | 1 | 4 | endocardial cushion fusion |
| GO:0003332 | 0.03117 | 42.16850 | 0 | 1 | 4 | negative regulation of extracellular matrix constituent secretion |
| GO:0003415 | 0.03117 | 42.16850 | 0 | 1 | 4 | chondrocyte hypertrophy |
| GO:0003431 | 0.03117 | 42.16850 | 0 | 1 | 4 | growth plate cartilage chondrocyte development |
| GO:0006598 | 0.03117 | 42.16850 | 0 | 1 | 4 | polyamine catabolic process |
| GO:0006931 | 0.03117 | 42.16850 | 0 | 1 | 4 | substrate-dependent cell migration, cell attachment to substrate |
| GO:0008592 | 0.03117 | 42.16850 | 0 | 1 | 4 | regulation of Toll signaling pathway |
| GO:0010536 | 0.03117 | 42.16850 | 0 | 1 | 4 | positive regulation of activation of Janus kinase activity |
| GO:0010750 | 0.03117 | 42.16850 | 0 | 1 | 4 | positive regulation of nitric oxide mediated signal transduction |
| GO:0014826 | 0.03117 | 42.16850 | 0 | 1 | 4 | vein smooth muscle contraction |
| GO:0014839 | 0.03117 | 42.16850 | 0 | 1 | 4 | myoblast migration involved in skeletal muscle regeneration |
| GO:0021815 | 0.03117 | 42.16850 | 0 | 1 | 4 | modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration |
| GO:0032345 | 0.03117 | 42.16850 | 0 | 1 | 4 | negative regulation of aldosterone metabolic process |
| GO:0032348 | 0.03117 | 42.16850 | 0 | 1 | 4 | negative regulation of aldosterone biosynthetic process |
| GO:0032497 | 0.03117 | 42.16850 | 0 | 1 | 4 | detection of lipopolysaccharide |
| GO:0036146 | 0.03117 | 42.16850 | 0 | 1 | 4 | cellular response to mycotoxin |
| GO:0036446 | 0.03117 | 42.16850 | 0 | 1 | 4 | myofibroblast differentiation |
| GO:0043378 | 0.03117 | 42.16850 | 0 | 1 | 4 | positive regulation of CD8-positive, alpha-beta T cell differentiation |
| GO:0043435 | 0.03117 | 42.16850 | 0 | 1 | 4 | response to corticotropin-releasing hormone |
| GO:0046013 | 0.03117 | 42.16850 | 0 | 1 | 4 | regulation of T cell homeostatic proliferation |
| GO:0048104 | 0.03117 | 42.16850 | 0 | 1 | 4 | establishment of body hair or bristle planar orientation |
| GO:0048105 | 0.03117 | 42.16850 | 0 | 1 | 4 | establishment of body hair planar orientation |
| GO:0060061 | 0.03117 | 42.16850 | 0 | 1 | 4 | Spemann organizer formation |
| GO:0060594 | 0.03117 | 42.16850 | 0 | 1 | 4 | mammary gland specification |
| GO:0060819 | 0.03117 | 42.16850 | 0 | 1 | 4 | inactivation of X chromosome by genetic imprinting |
| GO:0061110 | 0.03117 | 42.16850 | 0 | 1 | 4 | dense core granule biogenesis |
| GO:0061181 | 0.03117 | 42.16850 | 0 | 1 | 4 | regulation of chondrocyte development |
| GO:0061355 | 0.03117 | 42.16850 | 0 | 1 | 4 | Wnt protein secretion |
| GO:0061356 | 0.03117 | 42.16850 | 0 | 1 | 4 | regulation of Wnt protein secretion |
| GO:0061739 | 0.03117 | 42.16850 | 0 | 1 | 4 | protein lipidation involved in autophagosome assembly |
| GO:0070358 | 0.03117 | 42.16850 | 0 | 1 | 4 | actin polymerization-dependent cell motility |
| GO:0070602 | 0.03117 | 42.16850 | 0 | 1 | 4 | regulation of centromeric sister chromatid cohesion |
| GO:0071376 | 0.03117 | 42.16850 | 0 | 1 | 4 | cellular response to corticotropin-releasing hormone stimulus |
| GO:0071503 | 0.03117 | 42.16850 | 0 | 1 | 4 | response to heparin |
| GO:0071504 | 0.03117 | 42.16850 | 0 | 1 | 4 | cellular response to heparin |
| GO:0072223 | 0.03117 | 42.16850 | 0 | 1 | 4 | metanephric glomerular mesangium development |
| GO:0072262 | 0.03117 | 42.16850 | 0 | 1 | 4 | metanephric glomerular mesangial cell proliferation involved in metanephros development |
| GO:0089700 | 0.03117 | 42.16850 | 0 | 1 | 4 | protein kinase D signaling |
| GO:0090214 | 0.03117 | 42.16850 | 0 | 1 | 4 | spongiotrophoblast layer developmental growth |
| GO:0090521 | 0.03117 | 42.16850 | 0 | 1 | 4 | glomerular visceral epithelial cell migration |
| GO:0097360 | 0.03117 | 42.16850 | 0 | 1 | 4 | chorionic trophoblast cell proliferation |
| GO:1901382 | 0.03117 | 42.16850 | 0 | 1 | 4 | regulation of chorionic trophoblast cell proliferation |
| GO:1901491 | 0.03117 | 42.16850 | 0 | 1 | 4 | negative regulation of lymphangiogenesis |
| GO:1901529 | 0.03117 | 42.16850 | 0 | 1 | 4 | positive regulation of anion channel activity |
| GO:1903121 | 0.03117 | 42.16850 | 0 | 1 | 4 | regulation of TRAIL-activated apoptotic signaling pathway |
| GO:1903348 | 0.03117 | 42.16850 | 0 | 1 | 4 | positive regulation of bicellular tight junction assembly |
| GO:1903797 | 0.03117 | 42.16850 | 0 | 1 | 4 | positive regulation of inorganic anion transmembrane transport |
| GO:1904760 | 0.03117 | 42.16850 | 0 | 1 | 4 | regulation of myofibroblast differentiation |
| GO:1905460 | 0.03117 | 42.16850 | 0 | 1 | 4 | negative regulation of vascular associated smooth muscle cell apoptotic process |
| GO:1990086 | 0.03117 | 42.16850 | 0 | 1 | 4 | lens fiber cell apoptotic process |
| GO:1990839 | 0.03117 | 42.16850 | 0 | 1 | 4 | response to endothelin |
| GO:2000065 | 0.03117 | 42.16850 | 0 | 1 | 4 | negative regulation of cortisol biosynthetic process |
| GO:2000520 | 0.03117 | 42.16850 | 0 | 1 | 4 | regulation of immunological synapse formation |
| GO:2000563 | 0.03117 | 42.16850 | 0 | 1 | 4 | positive regulation of CD4-positive, alpha-beta T cell proliferation |
| GO:0050715 | 0.03119 | 3.50210 | 1 | 4 | 150 | positive regulation of cytokine secretion |
| GO:0035690 | 0.03149 | 2.41558 | 3 | 7 | 380 | cellular response to drug |
| GO:0010717 | 0.03155 | 4.55218 | 1 | 3 | 87 | regulation of epithelial to mesenchymal transition |
| GO:2000117 | 0.03155 | 4.55218 | 1 | 3 | 87 | negative regulation of cysteine-type endopeptidase activity |
| GO:0060326 | 0.03160 | 2.63018 | 2 | 6 | 299 | cell chemotaxis |
| GO:0031346 | 0.03195 | 2.25268 | 4 | 8 | 466 | positive regulation of cell projection organization |
| GO:0030073 | 0.03212 | 2.93900 | 2 | 5 | 223 | insulin secretion |
| GO:0046661 | 0.03251 | 3.45448 | 1 | 4 | 152 | male sex differentiation |
| GO:0051250 | 0.03251 | 3.45448 | 1 | 4 | 152 | negative regulation of lymphocyte activation |
| GO:0042311 | 0.03269 | 7.47254 | 0 | 2 | 36 | vasodilation |
| GO:0070528 | 0.03269 | 7.47254 | 0 | 2 | 36 | protein kinase C signaling |
| GO:2000516 | 0.03269 | 7.47254 | 0 | 2 | 36 | positive regulation of CD4-positive, alpha-beta T cell activation |
| GO:0006974 | 0.03312 | 1.95615 | 6 | 11 | 740 | cellular response to DNA damage stimulus |
| GO:0032675 | 0.03318 | 3.43114 | 1 | 4 | 153 | regulation of interleukin-6 production |
| GO:0032868 | 0.03319 | 2.91203 | 2 | 5 | 225 | response to insulin |
| GO:0001656 | 0.03342 | 4.44593 | 1 | 3 | 89 | metanephros development |
| GO:0031016 | 0.03342 | 4.44593 | 1 | 3 | 89 | pancreas development |
| GO:0035773 | 0.03342 | 4.44593 | 1 | 3 | 89 | insulin secretion involved in cellular response to glucose stimulus |
| GO:2000116 | 0.03373 | 2.89872 | 2 | 5 | 226 | regulation of cysteine-type endopeptidase activity |
| GO:0046677 | 0.03431 | 2.57672 | 2 | 6 | 305 | response to antibiotic |
| GO:0002753 | 0.03438 | 7.25872 | 0 | 2 | 37 | cytoplasmic pattern recognition receptor signaling pathway |
| GO:0007435 | 0.03438 | 7.25872 | 0 | 2 | 37 | salivary gland morphogenesis |
| GO:0019934 | 0.03438 | 7.25872 | 0 | 2 | 37 | cGMP-mediated signaling |
| GO:0021799 | 0.03438 | 7.25872 | 0 | 2 | 37 | cerebral cortex radially oriented cell migration |
| GO:0044085 | 0.03451 | 1.46416 | 24 | 33 | 3041 | cellular component biogenesis |
| GO:0051896 | 0.03456 | 3.38540 | 1 | 4 | 155 | regulation of protein kinase B signaling |
| GO:0030029 | 0.03480 | 1.93966 | 6 | 11 | 746 | actin filament-based process |
| GO:0046578 | 0.03483 | 2.87247 | 2 | 5 | 228 | regulation of Ras protein signal transduction |
| GO:0051606 | 0.03483 | 2.87247 | 2 | 5 | 228 | detection of stimulus |
| GO:0090276 | 0.03483 | 2.87247 | 2 | 5 | 228 | regulation of peptide hormone secretion |
| GO:0071383 | 0.03526 | 3.36298 | 1 | 4 | 156 | cellular response to steroid hormone stimulus |
| GO:1990845 | 0.03526 | 3.36298 | 1 | 4 | 156 | adaptive thermogenesis |
| GO:0036293 | 0.03596 | 2.84669 | 2 | 5 | 230 | response to decreased oxygen levels |
| GO:0007616 | 0.03610 | 7.05678 | 0 | 2 | 38 | long-term memory |
| GO:0014002 | 0.03610 | 7.05678 | 0 | 2 | 38 | astrocyte development |
| GO:0045622 | 0.03610 | 7.05678 | 0 | 2 | 38 | regulation of T-helper cell differentiation |
| GO:0046854 | 0.03610 | 7.05678 | 0 | 2 | 38 | phosphatidylinositol phosphorylation |
| GO:0048265 | 0.03610 | 7.05678 | 0 | 2 | 38 | response to pain |
| GO:0003012 | 0.03631 | 2.33905 | 3 | 7 | 392 | muscle system process |
| GO:0021543 | 0.03668 | 3.31902 | 1 | 4 | 158 | pallium development |
| GO:0032970 | 0.03673 | 2.33289 | 3 | 7 | 393 | regulation of actin filament-based process |
| GO:0009410 | 0.03710 | 2.82136 | 2 | 5 | 232 | response to xenobiotic stimulus |
| GO:0051251 | 0.03716 | 2.32676 | 3 | 7 | 394 | positive regulation of lymphocyte activation |
| GO:0043506 | 0.03734 | 4.24759 | 1 | 3 | 93 | regulation of JUN kinase activity |
| GO:0045445 | 0.03734 | 4.24759 | 1 | 3 | 93 | myoblast differentiation |
| GO:0010092 | 0.03786 | 6.86576 | 0 | 2 | 39 | specification of animal organ identity |
| GO:0046885 | 0.03786 | 6.86576 | 0 | 2 | 39 | regulation of hormone biosynthetic process |
| GO:0050931 | 0.03786 | 6.86576 | 0 | 2 | 39 | pigment cell differentiation |
| GO:0071174 | 0.03786 | 6.86576 | 0 | 2 | 39 | mitotic spindle checkpoint |
| GO:1901988 | 0.03813 | 3.27618 | 1 | 4 | 160 | negative regulation of cell cycle phase transition |
| GO:0060021 | 0.03835 | 4.20073 | 1 | 3 | 94 | roof of mouth development |
| GO:0006066 | 0.03866 | 2.50044 | 2 | 6 | 314 | alcohol metabolic process |
| GO:0051321 | 0.03866 | 2.50044 | 2 | 6 | 314 | meiotic cell cycle |
| GO:0001777 | 0.03881 | 31.62500 | 0 | 1 | 5 | T cell homeostatic proliferation |
| GO:0001978 | 0.03881 | 31.62500 | 0 | 1 | 5 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback |
| GO:0006701 | 0.03881 | 31.62500 | 0 | 1 | 5 | progesterone biosynthetic process |
| GO:0007494 | 0.03881 | 31.62500 | 0 | 1 | 5 | midgut development |
| GO:0014028 | 0.03881 | 31.62500 | 0 | 1 | 5 | notochord formation |
| GO:0015705 | 0.03881 | 31.62500 | 0 | 1 | 5 | iodide transport |
| GO:0031944 | 0.03881 | 31.62500 | 0 | 1 | 5 | negative regulation of glucocorticoid metabolic process |
| GO:0031947 | 0.03881 | 31.62500 | 0 | 1 | 5 | negative regulation of glucocorticoid biosynthetic process |
| GO:0033227 | 0.03881 | 31.62500 | 0 | 1 | 5 | dsRNA transport |
| GO:0035426 | 0.03881 | 31.62500 | 0 | 1 | 5 | extracellular matrix-cell signaling |
| GO:0035666 | 0.03881 | 31.62500 | 0 | 1 | 5 | TRIF-dependent toll-like receptor signaling pathway |
| GO:0042078 | 0.03881 | 31.62500 | 0 | 1 | 5 | germ-line stem cell division |
| GO:0042701 | 0.03881 | 31.62500 | 0 | 1 | 5 | progesterone secretion |
| GO:0045875 | 0.03881 | 31.62500 | 0 | 1 | 5 | negative regulation of sister chromatid cohesion |
| GO:0048133 | 0.03881 | 31.62500 | 0 | 1 | 5 | male germ-line stem cell asymmetric division |
| GO:0048319 | 0.03881 | 31.62500 | 0 | 1 | 5 | axial mesoderm morphogenesis |
| GO:0048386 | 0.03881 | 31.62500 | 0 | 1 | 5 | positive regulation of retinoic acid receptor signaling pathway |
| GO:0048496 | 0.03881 | 31.62500 | 0 | 1 | 5 | maintenance of animal organ identity |
| GO:0051121 | 0.03881 | 31.62500 | 0 | 1 | 5 | hepoxilin metabolic process |
| GO:0051122 | 0.03881 | 31.62500 | 0 | 1 | 5 | hepoxilin biosynthetic process |
| GO:0051754 | 0.03881 | 31.62500 | 0 | 1 | 5 | meiotic sister chromatid cohesion, centromeric |
| GO:0061304 | 0.03881 | 31.62500 | 0 | 1 | 5 | retinal blood vessel morphogenesis |
| GO:0061476 | 0.03881 | 31.62500 | 0 | 1 | 5 | response to anticoagulant |
| GO:0070120 | 0.03881 | 31.62500 | 0 | 1 | 5 | ciliary neurotrophic factor-mediated signaling pathway |
| GO:0070424 | 0.03881 | 31.62500 | 0 | 1 | 5 | regulation of nucleotide-binding oligomerization domain containing signaling pathway |
| GO:0070427 | 0.03881 | 31.62500 | 0 | 1 | 5 | nucleotide-binding oligomerization domain containing 1 signaling pathway |
| GO:0070432 | 0.03881 | 31.62500 | 0 | 1 | 5 | regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway |
| GO:0072300 | 0.03881 | 31.62500 | 0 | 1 | 5 | positive regulation of metanephric glomerulus development |
| GO:0090271 | 0.03881 | 31.62500 | 0 | 1 | 5 | positive regulation of fibroblast growth factor production |
| GO:0098728 | 0.03881 | 31.62500 | 0 | 1 | 5 | germline stem cell asymmetric division |
| GO:1900034 | 0.03881 | 31.62500 | 0 | 1 | 5 | regulation of cellular response to heat |
| GO:1901842 | 0.03881 | 31.62500 | 0 | 1 | 5 | negative regulation of high voltage-gated calcium channel activity |
| GO:1902308 | 0.03881 | 31.62500 | 0 | 1 | 5 | regulation of peptidyl-serine dephosphorylation |
| GO:1902498 | 0.03881 | 31.62500 | 0 | 1 | 5 | regulation of protein autoubiquitination |
| GO:1902744 | 0.03881 | 31.62500 | 0 | 1 | 5 | negative regulation of lamellipodium organization |
| GO:1902949 | 0.03881 | 31.62500 | 0 | 1 | 5 | positive regulation of tau-protein kinase activity |
| GO:1903912 | 0.03881 | 31.62500 | 0 | 1 | 5 | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation |
| GO:1903969 | 0.03881 | 31.62500 | 0 | 1 | 5 | regulation of response to macrophage colony-stimulating factor |
| GO:1903972 | 0.03881 | 31.62500 | 0 | 1 | 5 | regulation of cellular response to macrophage colony-stimulating factor stimulus |
| GO:1905007 | 0.03881 | 31.62500 | 0 | 1 | 5 | positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation |
| GO:1990441 | 0.03881 | 31.62500 | 0 | 1 | 5 | negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress |
| GO:2000196 | 0.03881 | 31.62500 | 0 | 1 | 5 | positive regulation of female gonad development |
| GO:0007264 | 0.03897 | 2.16113 | 4 | 8 | 485 | small GTPase mediated signal transduction |
| GO:0001704 | 0.03938 | 4.15489 | 1 | 3 | 95 | formation of primary germ layer |
| GO:0007173 | 0.03938 | 4.15489 | 1 | 3 | 95 | epidermal growth factor receptor signaling pathway |
| GO:0046916 | 0.03938 | 4.15489 | 1 | 3 | 95 | cellular transition metal ion homeostasis |
| GO:0051304 | 0.03938 | 4.15489 | 1 | 3 | 95 | chromosome separation |
| GO:0032635 | 0.03962 | 3.23442 | 1 | 4 | 162 | interleukin-6 production |
| GO:0030225 | 0.03965 | 6.68479 | 0 | 2 | 40 | macrophage differentiation |
| GO:0032620 | 0.03965 | 6.68479 | 0 | 2 | 40 | interleukin-17 production |
| GO:0060603 | 0.03965 | 6.68479 | 0 | 2 | 40 | mammary gland duct morphogenesis |
| GO:0006979 | 0.03978 | 2.29063 | 3 | 7 | 400 | response to oxidative stress |
| GO:0034976 | 0.04007 | 2.75995 | 2 | 5 | 237 | response to endoplasmic reticulum stress |
| GO:0009991 | 0.04023 | 2.28471 | 3 | 7 | 401 | response to extracellular stimulus |
| GO:0009266 | 0.04038 | 3.21394 | 1 | 4 | 163 | response to temperature stimulus |
| GO:0048660 | 0.04038 | 3.21394 | 1 | 4 | 163 | regulation of smooth muscle cell proliferation |
| GO:0007200 | 0.04042 | 4.11004 | 1 | 3 | 96 | phospholipase C-activating G protein-coupled receptor signaling pathway |
| GO:0014066 | 0.04042 | 4.11004 | 1 | 3 | 96 | regulation of phosphatidylinositol 3-kinase signaling |
| GO:0046887 | 0.04114 | 3.19372 | 1 | 4 | 164 | positive regulation of hormone secretion |
| GO:1903522 | 0.04129 | 2.73612 | 2 | 5 | 239 | regulation of blood circulation |
| GO:0006509 | 0.04147 | 6.51310 | 0 | 2 | 41 | membrane protein ectodomain proteolysis |
| GO:0031577 | 0.04147 | 6.51310 | 0 | 2 | 41 | spindle checkpoint |
| GO:0032459 | 0.04147 | 6.51310 | 0 | 2 | 41 | regulation of protein oligomerization |
| GO:0045841 | 0.04147 | 6.51310 | 0 | 2 | 41 | negative regulation of mitotic metaphase/anaphase transition |
| GO:0046782 | 0.04147 | 6.51310 | 0 | 2 | 41 | regulation of viral transcription |
| GO:0060122 | 0.04147 | 6.51310 | 0 | 2 | 41 | inner ear receptor cell stereocilium organization |
| GO:1900744 | 0.04147 | 6.51310 | 0 | 2 | 41 | regulation of p38MAPK cascade |
| GO:2001258 | 0.04147 | 6.51310 | 0 | 2 | 41 | negative regulation of cation channel activity |
| GO:0045132 | 0.04148 | 4.06613 | 1 | 3 | 97 | meiotic chromosome segregation |
| GO:0045638 | 0.04148 | 4.06613 | 1 | 3 | 97 | negative regulation of myeloid cell differentiation |
| GO:0046425 | 0.04192 | 3.17374 | 1 | 4 | 165 | regulation of JAK-STAT cascade |
| GO:0032760 | 0.04255 | 4.02316 | 1 | 3 | 98 | positive regulation of tumor necrosis factor production |
| GO:0071482 | 0.04255 | 4.02316 | 1 | 3 | 98 | cellular response to light stimulus |
| GO:2001237 | 0.04255 | 4.02316 | 1 | 3 | 98 | negative regulation of extrinsic apoptotic signaling pathway |
| GO:0042594 | 0.04270 | 3.15401 | 1 | 4 | 166 | response to starvation |
| GO:0045931 | 0.04270 | 3.15401 | 1 | 4 | 166 | positive regulation of mitotic cell cycle |
| GO:0010564 | 0.04287 | 2.01607 | 5 | 9 | 585 | regulation of cell cycle process |
| GO:0097178 | 0.04333 | 6.35000 | 0 | 2 | 42 | ruffle assembly |
| GO:2000816 | 0.04333 | 6.35000 | 0 | 2 | 42 | negative regulation of mitotic sister chromatid separation |
| GO:0032755 | 0.04363 | 3.98108 | 1 | 3 | 99 | positive regulation of interleukin-6 production |
| GO:0045639 | 0.04363 | 3.98108 | 1 | 3 | 99 | positive regulation of myeloid cell differentiation |
| GO:1903557 | 0.04363 | 3.98108 | 1 | 3 | 99 | positive regulation of tumor necrosis factor superfamily cytokine production |
| GO:0006260 | 0.04381 | 2.68967 | 2 | 5 | 243 | DNA replication |
| GO:0048659 | 0.04428 | 3.11527 | 1 | 4 | 168 | smooth muscle cell proliferation |
| GO:0050663 | 0.04445 | 2.67829 | 2 | 5 | 244 | cytokine secretion |
| GO:0001578 | 0.04473 | 3.93986 | 1 | 3 | 100 | microtubule bundle formation |
| GO:0002702 | 0.04473 | 3.93986 | 1 | 3 | 100 | positive regulation of production of molecular mediator of immune response |
| GO:2001242 | 0.04509 | 3.09626 | 1 | 4 | 169 | regulation of intrinsic apoptotic signaling pathway |
| GO:0010824 | 0.04521 | 6.19485 | 0 | 2 | 43 | regulation of centrosome duplication |
| GO:0032924 | 0.04521 | 6.19485 | 0 | 2 | 43 | activin receptor signaling pathway |
| GO:1902100 | 0.04521 | 6.19485 | 0 | 2 | 43 | negative regulation of metaphase/anaphase transition of cell cycle |
| GO:0031334 | 0.04575 | 2.65583 | 2 | 5 | 246 | positive regulation of protein complex assembly |
| GO:0003300 | 0.04584 | 3.89949 | 1 | 3 | 101 | cardiac muscle hypertrophy |
| GO:1901222 | 0.04584 | 3.89949 | 1 | 3 | 101 | regulation of NIK/NF-kappaB signaling |
| GO:1904892 | 0.04590 | 3.07747 | 1 | 4 | 170 | regulation of STAT cascade |
| GO:0007265 | 0.04637 | 2.21046 | 3 | 7 | 414 | Ras protein signal transduction |
| GO:0002322 | 0.04639 | 25.29890 | 0 | 1 | 6 | B cell proliferation involved in immune response |
| GO:0002513 | 0.04639 | 25.29890 | 0 | 1 | 6 | tolerance induction to self antigen |
| GO:0006501 | 0.04639 | 25.29890 | 0 | 1 | 6 | C-terminal protein lipidation |
| GO:0007182 | 0.04639 | 25.29890 | 0 | 1 | 6 | common-partner SMAD protein phosphorylation |
| GO:0010046 | 0.04639 | 25.29890 | 0 | 1 | 6 | response to mycotoxin |
| GO:0010496 | 0.04639 | 25.29890 | 0 | 1 | 6 | intercellular transport |
| GO:0010572 | 0.04639 | 25.29890 | 0 | 1 | 6 | positive regulation of platelet activation |
| GO:0010754 | 0.04639 | 25.29890 | 0 | 1 | 6 | negative regulation of cGMP-mediated signaling |
| GO:0014854 | 0.04639 | 25.29890 | 0 | 1 | 6 | response to inactivity |
| GO:0014870 | 0.04639 | 25.29890 | 0 | 1 | 6 | response to muscle inactivity |
| GO:0014877 | 0.04639 | 25.29890 | 0 | 1 | 6 | response to muscle inactivity involved in regulation of muscle adaptation |
| GO:0014894 | 0.04639 | 25.29890 | 0 | 1 | 6 | response to denervation involved in regulation of muscle adaptation |
| GO:0021631 | 0.04639 | 25.29890 | 0 | 1 | 6 | optic nerve morphogenesis |
| GO:0030174 | 0.04639 | 25.29890 | 0 | 1 | 6 | regulation of DNA-dependent DNA replication initiation |
| GO:0030321 | 0.04639 | 25.29890 | 0 | 1 | 6 | transepithelial chloride transport |
| GO:0031914 | 0.04639 | 25.29890 | 0 | 1 | 6 | negative regulation of synaptic plasticity |
| GO:0032792 | 0.04639 | 25.29890 | 0 | 1 | 6 | negative regulation of CREB transcription factor activity |
| GO:0043376 | 0.04639 | 25.29890 | 0 | 1 | 6 | regulation of CD8-positive, alpha-beta T cell differentiation |
| GO:0050722 | 0.04639 | 25.29890 | 0 | 1 | 6 | regulation of interleukin-1 beta biosynthetic process |
| GO:0050725 | 0.04639 | 25.29890 | 0 | 1 | 6 | positive regulation of interleukin-1 beta biosynthetic process |
| GO:0051454 | 0.04639 | 25.29890 | 0 | 1 | 6 | intracellular pH elevation |
| GO:0060708 | 0.04639 | 25.29890 | 0 | 1 | 6 | spongiotrophoblast differentiation |
| GO:0060718 | 0.04639 | 25.29890 | 0 | 1 | 6 | chorionic trophoblast cell differentiation |
| GO:0060729 | 0.04639 | 25.29890 | 0 | 1 | 6 | intestinal epithelial structure maintenance |
| GO:0070447 | 0.04639 | 25.29890 | 0 | 1 | 6 | positive regulation of oligodendrocyte progenitor proliferation |
| GO:0071500 | 0.04639 | 25.29890 | 0 | 1 | 6 | cellular response to nitrosative stress |
| GO:0072298 | 0.04639 | 25.29890 | 0 | 1 | 6 | regulation of metanephric glomerulus development |
| GO:0075044 | 0.04639 | 25.29890 | 0 | 1 | 6 | autophagy of host cells involved in interaction with symbiont |
| GO:0075071 | 0.04639 | 25.29890 | 0 | 1 | 6 | autophagy involved in symbiotic interaction |
| GO:0086073 | 0.04639 | 25.29890 | 0 | 1 | 6 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication |
| GO:0090027 | 0.04639 | 25.29890 | 0 | 1 | 6 | negative regulation of monocyte chemotaxis |
| GO:0090032 | 0.04639 | 25.29890 | 0 | 1 | 6 | negative regulation of steroid hormone biosynthetic process |
| GO:1900028 | 0.04639 | 25.29890 | 0 | 1 | 6 | negative regulation of ruffle assembly |
| GO:1900194 | 0.04639 | 25.29890 | 0 | 1 | 6 | negative regulation of oocyte maturation |
| GO:1901098 | 0.04639 | 25.29890 | 0 | 1 | 6 | positive regulation of autophagosome maturation |
| GO:1902262 | 0.04639 | 25.29890 | 0 | 1 | 6 | apoptotic process involved in blood vessel morphogenesis |
| GO:1903026 | 0.04639 | 25.29890 | 0 | 1 | 6 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding |
| GO:1904238 | 0.04639 | 25.29890 | 0 | 1 | 6 | pericyte cell differentiation |
| GO:1905005 | 0.04639 | 25.29890 | 0 | 1 | 6 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation |
| GO:2000015 | 0.04639 | 25.29890 | 0 | 1 | 6 | regulation of determination of dorsal identity |
| GO:2000064 | 0.04639 | 25.29890 | 0 | 1 | 6 | regulation of cortisol biosynthetic process |
| GO:2000074 | 0.04639 | 25.29890 | 0 | 1 | 6 | regulation of type B pancreatic cell development |
| GO:2000298 | 0.04639 | 25.29890 | 0 | 1 | 6 | regulation of Rho-dependent protein serine/threonine kinase activity |
| GO:2000554 | 0.04639 | 25.29890 | 0 | 1 | 6 | regulation of T-helper 1 cell cytokine production |
| GO:2000556 | 0.04639 | 25.29890 | 0 | 1 | 6 | positive regulation of T-helper 1 cell cytokine production |
| GO:2000672 | 0.04639 | 25.29890 | 0 | 1 | 6 | negative regulation of motor neuron apoptotic process |
| GO:2001268 | 0.04639 | 25.29890 | 0 | 1 | 6 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway |
| GO:0010506 | 0.04641 | 2.64474 | 2 | 5 | 247 | regulation of autophagy |
| GO:0032874 | 0.04672 | 3.05891 | 1 | 4 | 171 | positive regulation of stress-activated MAPK cascade |
| GO:0019218 | 0.04696 | 3.85993 | 1 | 3 | 102 | regulation of steroid metabolic process |
| GO:0046849 | 0.04696 | 3.85993 | 1 | 3 | 102 | bone remodeling |
| GO:1902106 | 0.04696 | 3.85993 | 1 | 3 | 102 | negative regulation of leukocyte differentiation |
| GO:1905477 | 0.04696 | 3.85993 | 1 | 3 | 102 | positive regulation of protein localization to membrane |
| GO:0019083 | 0.04712 | 6.04709 | 0 | 2 | 44 | viral transcription |
| GO:0042181 | 0.04712 | 6.04709 | 0 | 2 | 44 | ketone biosynthetic process |
| GO:0043616 | 0.04712 | 6.04709 | 0 | 2 | 44 | keratinocyte proliferation |
| GO:0070830 | 0.04712 | 6.04709 | 0 | 2 | 44 | bicellular tight junction assembly |
| GO:1905819 | 0.04712 | 6.04709 | 0 | 2 | 44 | negative regulation of chromosome separation |
| GO:0070304 | 0.04755 | 3.04057 | 1 | 4 | 172 | positive regulation of stress-activated protein kinase signaling cascade |
| GO:0006954 | 0.04777 | 1.89673 | 5 | 10 | 691 | inflammatory response |
| GO:0048589 | 0.04794 | 1.83380 | 6 | 11 | 787 | developmental growth |
| GO:0002063 | 0.04906 | 5.90621 | 0 | 2 | 45 | chondrocyte development |
| GO:0003254 | 0.04906 | 5.90621 | 0 | 2 | 45 | regulation of membrane depolarization |
| GO:0010259 | 0.04906 | 5.90621 | 0 | 2 | 45 | multicellular organism aging |
| GO:0033048 | 0.04906 | 5.90621 | 0 | 2 | 45 | negative regulation of mitotic sister chromatid segregation |
| GO:0035136 | 0.04906 | 5.90621 | 0 | 2 | 45 | forelimb morphogenesis |
| GO:0090184 | 0.04906 | 5.90621 | 0 | 2 | 45 | positive regulation of kidney development |
| GO:0120192 | 0.04906 | 5.90621 | 0 | 2 | 45 | tight junction assembly |
| GO:0001657 | 0.04925 | 3.78317 | 1 | 3 | 104 | ureteric bud development |
| GO:0072163 | 0.04925 | 3.78317 | 1 | 3 | 104 | mesonephric epithelium development |
| GO:0072164 | 0.04925 | 3.78317 | 1 | 3 | 104 | mesonephric tubule development |